id	sid	tid	token	lemma	pos
iajs-3527	1	1	7	7	NUM
iajs-3527	1	2	©	©	PROPN
iajs-3527	1	3	2025	2025	NUM
iajs-3527	1	4	the	the	DET
iajs-3527	1	5	author(s	author(s	NOUN
iajs-3527	1	6	)	)	PUNCT
iajs-3527	1	7	.	.	PUNCT
iajs-3527	2	1	published	publish	VERB
iajs-3527	2	2	by	by	ADP
iajs-3527	2	3	college	college	NOUN
iajs-3527	2	4	of	of	ADP
iajs-3527	2	5	education	education	NOUN
iajs-3527	2	6	for	for	ADP
iajs-3527	2	7	pure	pure	ADJ
iajs-3527	2	8	science	science	NOUN
iajs-3527	2	9	(	(	PUNCT
iajs-3527	2	10	ibn	ibn	PROPN
iajs-3527	2	11	al	al	PROPN
iajs-3527	2	12	-	-	PUNCT
iajs-3527	2	13	haitham	haitham	PROPN
iajs-3527	2	14	)	)	PUNCT
iajs-3527	2	15	,	,	PUNCT
iajs-3527	2	16	university	university	NOUN
iajs-3527	2	17	of	of	ADP
iajs-3527	2	18	baghdad	baghdad	PROPN
iajs-3527	2	19	.	.	PUNCT
iajs-3527	3	1	this	this	PRON
iajs-3527	3	2	is	be	AUX
iajs-3527	3	3	an	an	DET
iajs-3527	3	4	open	open	ADJ
iajs-3527	3	5	-	-	PUNCT
iajs-3527	3	6	access	access	NOUN
iajs-3527	3	7	article	article	NOUN
iajs-3527	3	8	distributed	distribute	VERB
iajs-3527	3	9	under	under	ADP
iajs-3527	3	10	the	the	DET
iajs-3527	3	11	terms	term	NOUN
iajs-3527	3	12	of	of	ADP
iajs-3527	3	13	the	the	DET
iajs-3527	3	14	creative	creative	ADJ
iajs-3527	3	15	commons	common	NOUN
iajs-3527	3	16	attribution	attribution	NOUN
iajs-3527	3	17	4.0	4.0	NUM
iajs-3527	3	18	international	international	ADJ
iajs-3527	3	19	license	license	NOUN
iajs-3527	3	20	evolution	evolution	NOUN
iajs-3527	3	21	of	of	ADP
iajs-3527	3	22	some	some	DET
iajs-3527	3	23	inflammatory	inflammatory	ADJ
iajs-3527	3	24	parameters	parameter	NOUN
iajs-3527	3	25	and	and	CCONJ
iajs-3527	3	26	tumor	tumor	NOUN
iajs-3527	3	27	necrosis	necrosis	NOUN
iajs-3527	3	28	factor	factor	NOUN
iajs-3527	3	29	alpha	alpha	NOUN
iajs-3527	3	30	in	in	ADP
iajs-3527	3	31	iraqi	iraqi	ADJ
iajs-3527	3	32	postmenopausal	postmenopausal	ADJ
iajs-3527	3	33	women	woman	NOUN
iajs-3527	3	34	with	with	ADP
iajs-3527	3	35	hypertension	hypertension	NOUN
iajs-3527	3	36	abeer	abeer	PROPN
iajs-3527	3	37	m.	m.	PROPN
iajs-3527	3	38	jassim	jassim	PROPN
iajs-3527	3	39	1	1	NUM
iajs-3527	3	40	*	*	PUNCT
iajs-3527	3	41	and	and	CCONJ
iajs-3527	3	42	zainab	zainab	PROPN
iajs-3527	3	43	k.	k.	PROPN
iajs-3527	3	44	hussain	hussain	PROPN
iajs-3527	3	45	2	2	NUM
iajs-3527	3	46	1,2	1,2	NUM
iajs-3527	3	47	department	department	NOUN
iajs-3527	3	48	of	of	ADP
iajs-3527	3	49	biology	biology	NOUN
iajs-3527	3	50	,	,	PUNCT
iajs-3527	3	51	college	college	NOUN
iajs-3527	3	52	of	of	ADP
iajs-3527	3	53	science	science	NOUN
iajs-3527	3	54	,	,	PUNCT
iajs-3527	3	55	university	university	NOUN
iajs-3527	3	56	of	of	ADP
iajs-3527	3	57	baghdad	baghdad	PROPN
iajs-3527	3	58	,	,	PUNCT
iajs-3527	3	59	baghdad	baghdad	PROPN
iajs-3527	3	60	,	,	PUNCT
iajs-3527	3	61	iraq	iraq	PROPN
iajs-3527	3	62	received	receive	VERB
iajs-3527	3	63	:	:	PUNCT
iajs-3527	3	64	24	24	NUM
iajs-3527	3	65	may	may	PROPN
iajs-3527	3	66	2023	2023	NUM
iajs-3527	3	67	accepted	accept	VERB
iajs-3527	3	68	:	:	PUNCT
iajs-3527	3	69	14	14	NUM
iajs-3527	3	70	august	august	PROPN
iajs-3527	3	71	2023	2023	NUM
iajs-3527	3	72	published	publish	VERB
iajs-3527	3	73	:	:	PUNCT
iajs-3527	3	74	20	20	NUM
iajs-3527	3	75	july	july	PROPN
iajs-3527	3	76	2025	2025	NUM
iajs-3527	3	77	doi.org/10.30526/38.3.3527	doi.org/10.30526/38.3.3527	VERB
iajs-3527	3	78	abstract	abstract	ADJ
iajs-3527	3	79	hypertension	hypertension	NOUN
iajs-3527	3	80	is	be	AUX
iajs-3527	3	81	a	a	DET
iajs-3527	3	82	global	global	ADJ
iajs-3527	3	83	health	health	NOUN
iajs-3527	3	84	concern	concern	NOUN
iajs-3527	3	85	,	,	PUNCT
iajs-3527	3	86	with	with	ADP
iajs-3527	3	87	women	woman	NOUN
iajs-3527	3	88	experiencing	experience	VERB
iajs-3527	3	89	lower	low	ADJ
iajs-3527	3	90	blood	blood	NOUN
iajs-3527	3	91	pressure	pressure	NOUN
iajs-3527	3	92	during	during	ADP
iajs-3527	3	93	their	their	PRON
iajs-3527	3	94	reproductive	reproductive	ADJ
iajs-3527	3	95	cycle	cycle	NOUN
iajs-3527	3	96	and	and	CCONJ
iajs-3527	3	97	postmenopausal	postmenopausal	ADJ
iajs-3527	3	98	women	woman	NOUN
iajs-3527	3	99	being	be	AUX
iajs-3527	3	100	more	more	ADV
iajs-3527	3	101	sensitive	sensitive	ADJ
iajs-3527	3	102	to	to	ADP
iajs-3527	3	103	it	it	PRON
iajs-3527	3	104	.	.	PUNCT
iajs-3527	4	1	postmenopausal	postmenopausal	PROPN
iajs-3527	4	2	women	woman	NOUN
iajs-3527	4	3	's	's	PART
iajs-3527	4	4	higher	high	ADJ
iajs-3527	4	5	body	body	NOUN
iajs-3527	4	6	mass	mass	NOUN
iajs-3527	4	7	increases	increase	VERB
iajs-3527	4	8	the	the	DET
iajs-3527	4	9	risk	risk	NOUN
iajs-3527	4	10	of	of	ADP
iajs-3527	4	11	hypertension	hypertension	NOUN
iajs-3527	4	12	,	,	PUNCT
iajs-3527	4	13	coronary	coronary	ADJ
iajs-3527	4	14	artery	artery	NOUN
iajs-3527	4	15	disease	disease	NOUN
iajs-3527	4	16	,	,	PUNCT
iajs-3527	4	17	and	and	CCONJ
iajs-3527	4	18	death	death	NOUN
iajs-3527	4	19	.	.	PUNCT
iajs-3527	5	1	venous	venous	ADJ
iajs-3527	5	2	blood	blood	NOUN
iajs-3527	5	3	was	be	AUX
iajs-3527	5	4	taken	take	VERB
iajs-3527	5	5	from	from	ADP
iajs-3527	5	6	women	woman	NOUN
iajs-3527	5	7	of	of	ADP
iajs-3527	5	8	experimental	experimental	ADJ
iajs-3527	5	9	groups	group	NOUN
iajs-3527	5	10	by	by	ADP
iajs-3527	5	11	syringes	syrinx	NOUN
iajs-3527	5	12	into	into	ADP
iajs-3527	5	13	gel	gel	NOUN
iajs-3527	5	14	tubes	tube	NOUN
iajs-3527	5	15	.	.	PUNCT
iajs-3527	6	1	blood	blood	NOUN
iajs-3527	6	2	serum	serum	NOUN
iajs-3527	6	3	was	be	AUX
iajs-3527	6	4	obtained	obtain	VERB
iajs-3527	6	5	after	after	ADP
iajs-3527	6	6	allowing	allow	VERB
iajs-3527	6	7	the	the	DET
iajs-3527	6	8	blood	blood	NOUN
iajs-3527	6	9	to	to	PART
iajs-3527	6	10	clot	clot	VERB
iajs-3527	6	11	in	in	ADP
iajs-3527	6	12	the	the	DET
iajs-3527	6	13	tube	tube	NOUN
iajs-3527	6	14	without	without	ADP
iajs-3527	6	15	anticoagulant	anticoagulant	NOUN
iajs-3527	6	16	for	for	ADP
iajs-3527	6	17	10	10	NUM
iajs-3527	6	18	-	-	SYM
iajs-3527	6	19	20	20	NUM
iajs-3527	6	20	min	min	NOUN
iajs-3527	6	21	at	at	ADP
iajs-3527	6	22	room	room	NOUN
iajs-3527	6	23	temperature	temperature	NOUN
iajs-3527	6	24	.	.	PUNCT
iajs-3527	7	1	to	to	PART
iajs-3527	7	2	calculate	calculate	VERB
iajs-3527	7	3	(	(	PUNCT
iajs-3527	7	4	tnf	tnf	PROPN
iajs-3527	7	5	-	-	PUNCT
iajs-3527	7	6	alpha	alpha	PROPN
iajs-3527	7	7	,	,	PUNCT
iajs-3527	7	8	crp	crp	PROPN
iajs-3527	7	9	)	)	PUNCT
iajs-3527	7	10	for	for	ADP
iajs-3527	7	11	all	all	DET
iajs-3527	7	12	samples	sample	NOUN
iajs-3527	7	13	,	,	PUNCT
iajs-3527	7	14	serum	serum	NOUN
iajs-3527	7	15	separation	separation	NOUN
iajs-3527	7	16	was	be	AUX
iajs-3527	7	17	done	do	VERB
iajs-3527	7	18	by	by	ADP
iajs-3527	7	19	centrifuge	centrifuge	NOUN
iajs-3527	7	20	machine	machine	NOUN
iajs-3527	7	21	at	at	ADP
iajs-3527	7	22	3000rpm	3000rpm	NUM
iajs-3527	7	23	for	for	ADP
iajs-3527	7	24	five	five	NUM
iajs-3527	7	25	minutes	minute	NOUN
iajs-3527	7	26	.	.	PUNCT
iajs-3527	8	1	c	c	X
iajs-3527	8	2	-	-	PUNCT
iajs-3527	8	3	reactive	reactive	ADJ
iajs-3527	8	4	protein	protein	NOUN
iajs-3527	8	5	(	(	PUNCT
iajs-3527	8	6	crp	crp	NOUN
iajs-3527	8	7	)	)	PUNCT
iajs-3527	8	8	kit	kit	NOUN
iajs-3527	8	9	and	and	CCONJ
iajs-3527	8	10	(	(	PUNCT
iajs-3527	8	11	tnf	tnf	PROPN
iajs-3527	8	12	-	-	PUNCT
iajs-3527	8	13	alpha	alpha	NOUN
iajs-3527	8	14	)	)	PUNCT
iajs-3527	8	15	kit	kit	NOUN
iajs-3527	8	16	by	by	ADP
iajs-3527	8	17	using	use	VERB
iajs-3527	8	18	the	the	DET
iajs-3527	8	19	elisa	elisa	NOUN
iajs-3527	8	20	technique	technique	NOUN
iajs-3527	8	21	according	accord	VERB
iajs-3527	8	22	to	to	ADP
iajs-3527	8	23	the	the	DET
iajs-3527	8	24	manufacturer	manufacturer	NOUN
iajs-3527	8	25	's	's	PART
iajs-3527	8	26	instructions	instruction	NOUN
iajs-3527	8	27	of	of	ADP
iajs-3527	8	28	mybio	mybio	NOUN
iajs-3527	8	29	source	source	PROPN
iajs-3527	8	30	usa	usa	PROPN
iajs-3527	8	31	kit	kit	PROPN
iajs-3527	8	32	.	.	PUNCT
iajs-3527	9	1	the	the	DET
iajs-3527	9	2	results	result	NOUN
iajs-3527	9	3	showed	show	VERB
iajs-3527	9	4	that	that	SCONJ
iajs-3527	9	5	there	there	PRON
iajs-3527	9	6	was	be	VERB
iajs-3527	9	7	no	no	DET
iajs-3527	9	8	significant	significant	ADJ
iajs-3527	9	9	variation	variation	NOUN
iajs-3527	9	10	in	in	ADP
iajs-3527	9	11	age	age	NOUN
iajs-3527	9	12	(	(	PUNCT
iajs-3527	9	13	t	t	NOUN
iajs-3527	9	14	-	-	PUNCT
iajs-3527	9	15	test	test	NOUN
iajs-3527	9	16	)	)	PUNCT
iajs-3527	9	17	value	value	NOUN
iajs-3527	9	18	(	(	PUNCT
iajs-3527	9	19	2.348	2.348	NUM
iajs-3527	9	20	)	)	PUNCT
iajs-3527	9	21	in	in	ADP
iajs-3527	9	22	postmenopausal	postmenopausal	ADJ
iajs-3527	9	23	women	woman	NOUN
iajs-3527	9	24	in	in	ADP
iajs-3527	9	25	the	the	DET
iajs-3527	9	26	mean	mean	NOUN
iajs-3527	9	27	of	of	ADP
iajs-3527	9	28	patients	patient	NOUN
iajs-3527	9	29	(	(	PUNCT
iajs-3527	9	30	59.45±0.68	59.45±0.68	NUM
iajs-3527	9	31	)	)	PUNCT
iajs-3527	9	32	years	year	NOUN
iajs-3527	9	33	,	,	PUNCT
iajs-3527	9	34	while	while	SCONJ
iajs-3527	9	35	healthy	healthy	ADJ
iajs-3527	9	36	women	woman	NOUN
iajs-3527	9	37	were	be	AUX
iajs-3527	9	38	(	(	PUNCT
iajs-3527	9	39	57.50±0.97	57.50±0.97	PROPN
iajs-3527	9	40	)	)	PUNCT
iajs-3527	9	41	.	.	PUNCT
iajs-3527	10	1	there	there	PRON
iajs-3527	10	2	were	be	VERB
iajs-3527	10	3	significant	significant	ADJ
iajs-3527	10	4	changes	change	NOUN
iajs-3527	10	5	in	in	ADP
iajs-3527	10	6	body	body	NOUN
iajs-3527	10	7	mass	mass	NOUN
iajs-3527	10	8	index	index	NOUN
iajs-3527	10	9	(	(	PUNCT
iajs-3527	10	10	bmi	bmi	PROPN
iajs-3527	10	11	)	)	PUNCT
iajs-3527	10	12	in	in	ADP
iajs-3527	10	13	postmenopausal	postmenopausal	ADJ
iajs-3527	10	14	women	woman	NOUN
iajs-3527	10	15	(	(	PUNCT
iajs-3527	10	16	p≤0.01	p≤0.01	NOUN
iajs-3527	10	17	)	)	PUNCT
iajs-3527	10	18	that	that	PRON
iajs-3527	10	19	were	be	AUX
iajs-3527	10	20	found	find	VERB
iajs-3527	10	21	between	between	ADP
iajs-3527	10	22	the	the	DET
iajs-3527	10	23	mean	mean	NOUN
iajs-3527	10	24	of	of	ADP
iajs-3527	10	25	patients	patient	NOUN
iajs-3527	10	26	(	(	PUNCT
iajs-3527	10	27	28.19±0.59	28.19±0.59	NUM
iajs-3527	10	28	)	)	PUNCT
iajs-3527	10	29	and	and	CCONJ
iajs-3527	10	30	the	the	DET
iajs-3527	10	31	control	control	NOUN
iajs-3527	10	32	group	group	NOUN
iajs-3527	10	33	(	(	PUNCT
iajs-3527	10	34	25.65±0.19	25.65±0.19	NUM
iajs-3527	10	35	)	)	PUNCT
iajs-3527	10	36	.	.	PUNCT
iajs-3527	11	1	also	also	ADV
iajs-3527	11	2	,	,	PUNCT
iajs-3527	11	3	there	there	PRON
iajs-3527	11	4	were	be	VERB
iajs-3527	11	5	significant	significant	ADJ
iajs-3527	11	6	changes	change	NOUN
iajs-3527	11	7	(	(	PUNCT
iajs-3527	11	8	p≤0.01	p≤0.01	NOUN
iajs-3527	11	9	)	)	PUNCT
iajs-3527	11	10	in	in	ADP
iajs-3527	11	11	the	the	DET
iajs-3527	11	12	mean	mean	ADJ
iajs-3527	11	13	values	value	NOUN
iajs-3527	11	14	of	of	ADP
iajs-3527	11	15	blood	blood	NOUN
iajs-3527	11	16	pressure	pressure	NOUN
iajs-3527	11	17	diastole	diastole	NOUN
iajs-3527	11	18	(	(	PUNCT
iajs-3527	11	19	8.76±0.06	8.76±0.06	NUM
iajs-3527	11	20	)	)	PUNCT
iajs-3527	11	21	and	and	CCONJ
iajs-3527	11	22	systole	systole	PROPN
iajs-3527	11	23	(	(	PUNCT
iajs-3527	11	24	16.00±0.15	16.00±0.15	NUM
iajs-3527	11	25	)	)	PUNCT
iajs-3527	11	26	in	in	ADP
iajs-3527	11	27	postmenopausal	postmenopausal	ADJ
iajs-3527	11	28	women	woman	NOUN
iajs-3527	11	29	compared	compare	VERB
iajs-3527	11	30	with	with	ADP
iajs-3527	11	31	the	the	DET
iajs-3527	11	32	control	control	NOUN
iajs-3527	11	33	group	group	NOUN
iajs-3527	11	34	with	with	ADP
iajs-3527	11	35	mean	mean	ADJ
iajs-3527	11	36	values	value	NOUN
iajs-3527	11	37	(	(	PUNCT
iajs-3527	11	38	7.73±0.12	7.73±0.12	NOUN
iajs-3527	11	39	)	)	PUNCT
iajs-3527	11	40	and	and	CCONJ
iajs-3527	11	41	(	(	PUNCT
iajs-3527	11	42	11.60±0.14	11.60±0.14	NUM
iajs-3527	11	43	)	)	PUNCT
iajs-3527	11	44	,	,	PUNCT
iajs-3527	11	45	sequentially	sequentially	ADV
iajs-3527	11	46	.	.	PUNCT
iajs-3527	12	1	significant	significant	ADJ
iajs-3527	12	2	difference	difference	NOUN
iajs-3527	12	3	(	(	PUNCT
iajs-3527	12	4	p≤0.01	p≤0.01	NOUN
iajs-3527	12	5	)	)	PUNCT
iajs-3527	12	6	in	in	ADP
iajs-3527	12	7	mean	mean	ADJ
iajs-3527	12	8	value	value	NOUN
iajs-3527	12	9	of	of	ADP
iajs-3527	12	10	hb	hb	PROPN
iajs-3527	12	11	patient	patient	ADJ
iajs-3527	12	12	women	woman	NOUN
iajs-3527	12	13	(	(	PUNCT
iajs-3527	12	14	12.89±0.16	12.89±0.16	NUM
iajs-3527	12	15	)	)	PUNCT
iajs-3527	12	16	as	as	ADP
iajs-3527	12	17	compared	compare	VERB
iajs-3527	12	18	with	with	ADP
iajs-3527	12	19	healthy	healthy	ADJ
iajs-3527	12	20	women	woman	NOUN
iajs-3527	12	21	(	(	PUNCT
iajs-3527	12	22	12.32±0.24	12.32±0.24	NUM
iajs-3527	12	23	)	)	PUNCT
iajs-3527	12	24	.	.	PUNCT
iajs-3527	13	1	no	no	DET
iajs-3527	13	2	significant	significant	ADJ
iajs-3527	13	3	changes	change	NOUN
iajs-3527	13	4	in	in	ADP
iajs-3527	13	5	mean	mean	ADJ
iajs-3527	13	6	value	value	NOUN
iajs-3527	13	7	of	of	ADP
iajs-3527	13	8	platelets	platelet	NOUN
iajs-3527	13	9	(	(	PUNCT
iajs-3527	13	10	253.90±970	253.90±970	NUM
iajs-3527	13	11	)	)	PUNCT
iajs-3527	13	12	and	and	CCONJ
iajs-3527	13	13	wbcs	wbc	NOUN
iajs-3527	13	14	(	(	PUNCT
iajs-3527	13	15	7.97±0.39	7.97±0.39	NOUN
iajs-3527	13	16	)	)	PUNCT
iajs-3527	13	17	in	in	ADP
iajs-3527	13	18	patient	patient	ADJ
iajs-3527	13	19	postmenopausal	postmenopausal	ADJ
iajs-3527	13	20	women	woman	NOUN
iajs-3527	13	21	with	with	ADP
iajs-3527	13	22	control	control	NOUN
iajs-3527	13	23	group	group	NOUN
iajs-3527	13	24	(	(	PUNCT
iajs-3527	13	25	251±12.34	251±12.34	NUM
iajs-3527	13	26	)	)	PUNCT
iajs-3527	13	27	and	and	CCONJ
iajs-3527	13	28	(	(	PUNCT
iajs-3527	13	29	7.87±0.32	7.87±0.32	NUM
iajs-3527	13	30	)	)	PUNCT
iajs-3527	13	31	,	,	PUNCT
iajs-3527	13	32	respectively	respectively	ADV
iajs-3527	13	33	.	.	PUNCT
iajs-3527	14	1	significant	significant	ADJ
iajs-3527	14	2	change	change	NOUN
iajs-3527	14	3	(	(	PUNCT
iajs-3527	14	4	p≤0.01	p≤0.01	NOUN
iajs-3527	14	5	)	)	PUNCT
iajs-3527	14	6	in	in	ADP
iajs-3527	14	7	mean	mean	ADJ
iajs-3527	14	8	value	value	NOUN
iajs-3527	14	9	of	of	ADP
iajs-3527	14	10	tnf	tnf	PROPN
iajs-3527	14	11	-	-	PUNCT
iajs-3527	14	12	alpha	alpha	NOUN
iajs-3527	14	13	patient	patient	ADJ
iajs-3527	14	14	women	woman	NOUN
iajs-3527	14	15	(	(	PUNCT
iajs-3527	14	16	146.79±4.45	146.79±4.45	NUM
iajs-3527	14	17	)	)	PUNCT
iajs-3527	14	18	as	as	SCONJ
iajs-3527	14	19	compared	compare	VERB
iajs-3527	14	20	with	with	ADP
iajs-3527	14	21	control	control	NOUN
iajs-3527	14	22	(	(	PUNCT
iajs-3527	14	23	66.13±1.32	66.13±1.32	NUM
iajs-3527	14	24	)	)	PUNCT
iajs-3527	14	25	.	.	PUNCT
iajs-3527	15	1	crp	crp	PROPN
iajs-3527	15	2	show	show	VERB
iajs-3527	15	3	a	a	DET
iajs-3527	15	4	significant	significant	ADJ
iajs-3527	15	5	difference	difference	NOUN
iajs-3527	15	6	(	(	PUNCT
iajs-3527	15	7	p≤0.01	p≤0.01	NOUN
iajs-3527	15	8	)	)	PUNCT
iajs-3527	15	9	in	in	ADP
iajs-3527	15	10	mean	mean	ADJ
iajs-3527	15	11	value	value	NOUN
iajs-3527	15	12	,	,	PUNCT
iajs-3527	15	13	with	with	ADP
iajs-3527	15	14	patients	patient	NOUN
iajs-3527	15	15	being	be	AUX
iajs-3527	15	16	women	woman	NOUN
iajs-3527	15	17	(	(	PUNCT
iajs-3527	15	18	2.37±0.10	2.37±0.10	NOUN
iajs-3527	15	19	)	)	PUNCT
iajs-3527	15	20	while	while	SCONJ
iajs-3527	15	21	the	the	DET
iajs-3527	15	22	control	control	NOUN
iajs-3527	15	23	group	group	NOUN
iajs-3527	15	24	was	be	AUX
iajs-3527	15	25	(	(	PUNCT
iajs-3527	15	26	0.813±0.04	0.813±0.04	NUM
iajs-3527	15	27	)	)	PUNCT
iajs-3527	15	28	.	.	PUNCT
iajs-3527	16	1	there	there	PRON
iajs-3527	16	2	was	be	VERB
iajs-3527	16	3	no	no	DET
iajs-3527	16	4	significant	significant	ADJ
iajs-3527	16	5	change	change	NOUN
iajs-3527	16	6	in	in	ADP
iajs-3527	16	7	the	the	DET
iajs-3527	16	8	esr	esr	PROPN
iajs-3527	16	9	mean	mean	NOUN
iajs-3527	16	10	of	of	ADP
iajs-3527	16	11	patients	patient	NOUN
iajs-3527	16	12	who	who	PRON
iajs-3527	16	13	were	be	AUX
iajs-3527	16	14	women	woman	NOUN
iajs-3527	16	15	(	(	PUNCT
iajs-3527	16	16	34.31±3.02	34.31±3.02	NUM
iajs-3527	16	17	)	)	PUNCT
iajs-3527	16	18	and	and	CCONJ
iajs-3527	16	19	the	the	DET
iajs-3527	16	20	control	control	NOUN
iajs-3527	16	21	group	group	NOUN
iajs-3527	16	22	(	(	PUNCT
iajs-3527	16	23	31.40±3.02	31.40±3.02	NUM
iajs-3527	16	24	)	)	PUNCT
iajs-3527	16	25	.	.	PUNCT
iajs-3527	17	1	keywords	keyword	NOUN
iajs-3527	17	2	:	:	PUNCT
iajs-3527	17	3	hypertension	hypertension	NOUN
iajs-3527	17	4	,	,	PUNCT
iajs-3527	17	5	tnf	tnf	PROPN
iajs-3527	17	6	-	-	PUNCT
iajs-3527	17	7	alpha	alpha	PROPN
iajs-3527	17	8	,	,	PUNCT
iajs-3527	17	9	postmenopausal	postmenopausal	NOUN
iajs-3527	17	10	,	,	PUNCT
iajs-3527	17	11	crp	crp	PROPN
iajs-3527	17	12	.	.	PROPN
iajs-3527	18	1	1	1	X
iajs-3527	18	2	.	.	X
iajs-3527	18	3	introduction	introduction	NOUN
iajs-3527	18	4	hypertension	hypertension	NOUN
iajs-3527	18	5	is	be	AUX
iajs-3527	18	6	one	one	NUM
iajs-3527	18	7	of	of	ADP
iajs-3527	18	8	the	the	DET
iajs-3527	18	9	main	main	ADJ
iajs-3527	18	10	reasons	reason	NOUN
iajs-3527	18	11	for	for	ADP
iajs-3527	18	12	malaise	malaise	NOUN
iajs-3527	18	13	and	and	CCONJ
iajs-3527	18	14	death	death	NOUN
iajs-3527	18	15	all	all	ADV
iajs-3527	18	16	around	around	ADP
iajs-3527	18	17	the	the	DET
iajs-3527	18	18	world	world	NOUN
iajs-3527	18	19	.	.	PUNCT
iajs-3527	19	1	it	it	PRON
iajs-3527	19	2	is	be	AUX
iajs-3527	19	3	known	know	VERB
iajs-3527	19	4	that	that	SCONJ
iajs-3527	19	5	women	woman	NOUN
iajs-3527	19	6	in	in	ADP
iajs-3527	19	7	their	their	PRON
iajs-3527	19	8	reproductive	reproductive	ADJ
iajs-3527	19	9	cycle	cycle	NOUN
iajs-3527	19	10	have	have	VERB
iajs-3527	19	11	a	a	DET
iajs-3527	19	12	bit	bit	NOUN
iajs-3527	19	13	lower	low	ADJ
iajs-3527	19	14	blood	blood	NOUN
iajs-3527	19	15	pressure	pressure	NOUN
iajs-3527	19	16	than	than	ADP
iajs-3527	19	17	men	man	NOUN
iajs-3527	19	18	of	of	ADP
iajs-3527	19	19	the	the	DET
iajs-3527	19	20	same	same	ADJ
iajs-3527	19	21	age	age	NOUN
iajs-3527	19	22	.	.	PUNCT
iajs-3527	20	1	while	while	SCONJ
iajs-3527	20	2	postmenopausal	postmenopausal	ADJ
iajs-3527	20	3	women	woman	NOUN
iajs-3527	20	4	with	with	ADP
iajs-3527	20	5	hypertension	hypertension	NOUN
iajs-3527	20	6	are	be	AUX
iajs-3527	20	7	more	more	ADV
iajs-3527	20	8	sensitive	sensitive	ADJ
iajs-3527	20	9	to	to	ADP
iajs-3527	20	10	https://orcid.org/0009-0006-9621-7619	https://orcid.org/0009-0006-9621-7619	PROPN
iajs-3527	20	11	mailto:abeermohammed9595@gmail.com	mailto:abeermohammed9595@gmail.com	PROPN
iajs-3527	20	12	https://orcid.org/0000-0002-4953-2783	https://orcid.org/0000-0002-4953-2783	PROPN
iajs-3527	20	13	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	PROPN
iajs-3527	20	14	https://orcid.org/0009-0006-9621-7619	https://orcid.org/0009-0006-9621-7619	PROPN
iajs-3527	20	15	mailto:abeermohammed9595@gmail.com	mailto:abeermohammed9595@gmail.com	PROPN
iajs-3527	20	16	https://orcid.org/0000-0002-4953-2783	https://orcid.org/0000-0002-4953-2783	PROPN
iajs-3527	20	17	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	PROPN
iajs-3527	20	18	https://orcid.org/0009-0006-9621-7619	https://orcid.org/0009-0006-9621-7619	PROPN
iajs-3527	20	19	mailto:abeermohammed9595@gmail.com	mailto:abeermohammed9595@gmail.com	PROPN
iajs-3527	20	20	https://orcid.org/0000-0002-4953-2783	https://orcid.org/0000-0002-4953-2783	PROPN
iajs-3527	20	21	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	PROPN
iajs-3527	20	22	https://orcid.org/0009-0006-9621-7619	https://orcid.org/0009-0006-9621-7619	PROPN
iajs-3527	20	23	mailto:abeermohammed9595@gmail.com	mailto:abeermohammed9595@gmail.com	PROPN
iajs-3527	20	24	https://orcid.org/0000-0002-4953-2783	https://orcid.org/0000-0002-4953-2783	PROPN
iajs-3527	20	25	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	PROPN
iajs-3527	20	26	https://orcid.org/0009-0006-9621-7619	https://orcid.org/0009-0006-9621-7619	PROPN
iajs-3527	20	27	mailto:abeermohammed9595@gmail.com	mailto:abeermohammed9595@gmail.com	PROPN
iajs-3527	20	28	https://orcid.org/0000-0002-4953-2783	https://orcid.org/0000-0002-4953-2783	PROPN
iajs-3527	20	29	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	PROPN
iajs-3527	20	30	https://orcid.org/0009-0006-9621-7619	https://orcid.org/0009-0006-9621-7619	PROPN
iajs-3527	20	31	mailto:abeermohammed9595@gmail.com	mailto:abeermohammed9595@gmail.com	PROPN
iajs-3527	20	32	https://orcid.org/0000-0002-4953-2783	https://orcid.org/0000-0002-4953-2783	PROPN
iajs-3527	20	33	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	mailto:zainab.khidhair@sc.uobaghdad.edu.iq	PROPN
iajs-3527	20	34	ihjpas	ihjpas	PROPN
iajs-3527	20	35	.	.	PUNCT
iajs-3527	21	1	2025	2025	NUM
iajs-3527	21	2	,	,	PUNCT
iajs-3527	21	3	38(3	38(3	NUM
iajs-3527	21	4	)	)	PUNCT
iajs-3527	21	5	8	8	NUM
iajs-3527	21	6	evolving	evolve	VERB
iajs-3527	21	7	hypertension	hypertension	NOUN
iajs-3527	21	8	with	with	ADP
iajs-3527	21	9	minor	minor	ADJ
iajs-3527	21	10	responses	response	NOUN
iajs-3527	21	11	to	to	ADP
iajs-3527	21	12	therapies	therapy	NOUN
iajs-3527	21	13	in	in	ADP
iajs-3527	21	14	contrast	contrast	NOUN
iajs-3527	21	15	to	to	ADP
iajs-3527	21	16	men	man	NOUN
iajs-3527	21	17	of	of	ADP
iajs-3527	21	18	similar	similar	ADJ
iajs-3527	21	19	age	age	NOUN
iajs-3527	21	20	(	(	PUNCT
iajs-3527	21	21	1	1	NUM
iajs-3527	21	22	)	)	PUNCT
iajs-3527	21	23	.	.	PUNCT
iajs-3527	22	1	particularly	particularly	ADV
iajs-3527	22	2	,	,	PUNCT
iajs-3527	22	3	blood	blood	NOUN
iajs-3527	22	4	pressure	pressure	NOUN
iajs-3527	22	5	paths	path	NOUN
iajs-3527	22	6	can	can	AUX
iajs-3527	22	7	differ	differ	VERB
iajs-3527	22	8	by	by	ADP
iajs-3527	22	9	age	age	NOUN
iajs-3527	22	10	and	and	CCONJ
iajs-3527	22	11	may	may	AUX
iajs-3527	22	12	be	be	AUX
iajs-3527	22	13	linked	link	VERB
iajs-3527	22	14	to	to	ADP
iajs-3527	22	15	other	other	ADJ
iajs-3527	22	16	levels	level	NOUN
iajs-3527	22	17	of	of	ADP
iajs-3527	22	18	cardiovascular	cardiovascular	ADJ
iajs-3527	22	19	disease	disease	NOUN
iajs-3527	22	20	(	(	PUNCT
iajs-3527	22	21	2	2	NUM
iajs-3527	22	22	,	,	PUNCT
iajs-3527	22	23	3	3	NUM
iajs-3527	22	24	)	)	PUNCT
iajs-3527	22	25	.	.	PUNCT
iajs-3527	23	1	factors	factor	NOUN
iajs-3527	23	2	involved	involve	VERB
iajs-3527	23	3	in	in	ADP
iajs-3527	23	4	elevating	elevate	VERB
iajs-3527	23	5	hypertension	hypertension	NOUN
iajs-3527	23	6	included	include	VERB
iajs-3527	23	7	age	age	NOUN
iajs-3527	23	8	,	,	PUNCT
iajs-3527	23	9	gender	gender	NOUN
iajs-3527	23	10	,	,	PUNCT
iajs-3527	23	11	smoking	smoking	NOUN
iajs-3527	23	12	,	,	PUNCT
iajs-3527	23	13	bmi	bmi	NOUN
iajs-3527	23	14	,	,	PUNCT
iajs-3527	23	15	diets	diet	NOUN
iajs-3527	23	16	,	,	PUNCT
iajs-3527	23	17	and	and	CCONJ
iajs-3527	23	18	family	family	NOUN
iajs-3527	23	19	history	history	NOUN
iajs-3527	23	20	(	(	PUNCT
iajs-3527	23	21	4	4	NUM
iajs-3527	23	22	-	-	SYM
iajs-3527	23	23	6	6	NUM
iajs-3527	23	24	)	)	PUNCT
iajs-3527	23	25	.	.	PUNCT
iajs-3527	24	1	women	woman	NOUN
iajs-3527	24	2	during	during	ADP
iajs-3527	24	3	post	post	NOUN
iajs-3527	24	4	menopause	menopause	NOUN
iajs-3527	24	5	have	have	VERB
iajs-3527	24	6	a	a	DET
iajs-3527	24	7	higher	high	ADJ
iajs-3527	24	8	body	body	NOUN
iajs-3527	24	9	mass	mass	NOUN
iajs-3527	24	10	than	than	ADP
iajs-3527	24	11	premenopausal	premenopausal	ADJ
iajs-3527	24	12	women	woman	NOUN
iajs-3527	24	13	.	.	PUNCT
iajs-3527	25	1	being	be	AUX
iajs-3527	25	2	overweight	overweight	ADJ
iajs-3527	25	3	in	in	ADP
iajs-3527	25	4	postmenopausal	postmenopausal	ADJ
iajs-3527	25	5	women	woman	NOUN
iajs-3527	25	6	led	lead	VERB
iajs-3527	25	7	to	to	ADP
iajs-3527	25	8	raising	raise	VERB
iajs-3527	25	9	the	the	DET
iajs-3527	25	10	probability	probability	NOUN
iajs-3527	25	11	of	of	ADP
iajs-3527	25	12	hypertension	hypertension	NOUN
iajs-3527	25	13	,	,	PUNCT
iajs-3527	25	14	coronary	coronary	ADJ
iajs-3527	25	15	artery	artery	NOUN
iajs-3527	25	16	disease	disease	NOUN
iajs-3527	25	17	,	,	PUNCT
iajs-3527	25	18	and	and	CCONJ
iajs-3527	25	19	death	death	NOUN
iajs-3527	25	20	(	(	PUNCT
iajs-3527	25	21	7	7	NUM
iajs-3527	25	22	)	)	PUNCT
iajs-3527	25	23	.	.	PUNCT
iajs-3527	26	1	just	just	ADV
iajs-3527	26	2	as	as	SCONJ
iajs-3527	26	3	in	in	ADP
iajs-3527	26	4	several	several	ADJ
iajs-3527	26	5	data	datum	NOUN
iajs-3527	26	6	that	that	PRON
iajs-3527	26	7	reveal	reveal	VERB
iajs-3527	26	8	c	c	NOUN
iajs-3527	26	9	-	-	ADJ
iajs-3527	26	10	reactive	reactive	ADJ
iajs-3527	26	11	protein	protein	NOUN
iajs-3527	26	12	(	(	PUNCT
iajs-3527	26	13	crp	crp	NOUN
iajs-3527	26	14	)	)	PUNCT
iajs-3527	26	15	is	be	AUX
iajs-3527	26	16	related	relate	VERB
iajs-3527	26	17	to	to	ADP
iajs-3527	26	18	cvd	cvd	PROPN
iajs-3527	26	19	,	,	PUNCT
iajs-3527	26	20	diabetes	diabetes	NOUN
iajs-3527	26	21	,	,	PUNCT
iajs-3527	26	22	metabolic	metabolic	NOUN
iajs-3527	26	23	syndrome	syndrome	NOUN
iajs-3527	26	24	,	,	PUNCT
iajs-3527	26	25	and	and	CCONJ
iajs-3527	26	26	dyslipidemia	dyslipidemia	VERB
iajs-3527	26	27	,	,	PUNCT
iajs-3527	26	28	it	it	PRON
iajs-3527	26	29	may	may	AUX
iajs-3527	26	30	be	be	AUX
iajs-3527	26	31	used	use	VERB
iajs-3527	26	32	as	as	ADP
iajs-3527	26	33	an	an	DET
iajs-3527	26	34	indicator	indicator	NOUN
iajs-3527	26	35	for	for	ADP
iajs-3527	26	36	long	long	ADJ
iajs-3527	26	37	-	-	PUNCT
iajs-3527	26	38	term	term	NOUN
iajs-3527	26	39	monitoring	monitoring	NOUN
iajs-3527	26	40	or	or	CCONJ
iajs-3527	26	41	early	early	ADJ
iajs-3527	26	42	screening	screening	NOUN
iajs-3527	26	43	that	that	PRON
iajs-3527	26	44	is	be	AUX
iajs-3527	26	45	important	important	ADJ
iajs-3527	26	46	background	background	NOUN
iajs-3527	26	47	for	for	ADP
iajs-3527	26	48	patients	patient	NOUN
iajs-3527	26	49	diagnosis	diagnosis	NOUN
iajs-3527	26	50	(	(	PUNCT
iajs-3527	26	51	8	8	NUM
iajs-3527	26	52	-	-	SYM
iajs-3527	26	53	10	10	NUM
iajs-3527	26	54	)	)	PUNCT
iajs-3527	26	55	.	.	PUNCT
iajs-3527	27	1	creactive	creactive	ADJ
iajs-3527	27	2	protein	protein	NOUN
iajs-3527	27	3	is	be	AUX
iajs-3527	27	4	considered	consider	VERB
iajs-3527	27	5	a	a	DET
iajs-3527	27	6	prophesy	prophesy	NOUN
iajs-3527	27	7	of	of	ADP
iajs-3527	27	8	opportunity	opportunity	NOUN
iajs-3527	27	9	for	for	ADP
iajs-3527	27	10	cardiac	cardiac	ADJ
iajs-3527	27	11	disorders	disorder	NOUN
iajs-3527	27	12	,	,	PUNCT
iajs-3527	27	13	peripheral	peripheral	ADJ
iajs-3527	27	14	vascular	vascular	ADJ
iajs-3527	27	15	disease	disease	NOUN
iajs-3527	27	16	,	,	PUNCT
iajs-3527	27	17	and	and	CCONJ
iajs-3527	27	18	stroke	stroke	NOUN
iajs-3527	27	19	.	.	PUNCT
iajs-3527	28	1	it	it	PRON
iajs-3527	28	2	could	could	AUX
iajs-3527	28	3	be	be	AUX
iajs-3527	28	4	used	use	VERB
iajs-3527	28	5	as	as	ADP
iajs-3527	28	6	an	an	DET
iajs-3527	28	7	indicator	indicator	NOUN
iajs-3527	28	8	for	for	ADP
iajs-3527	28	9	future	future	ADJ
iajs-3527	28	10	risk	risk	NOUN
iajs-3527	28	11	in	in	ADP
iajs-3527	28	12	patients	patient	NOUN
iajs-3527	28	13	with	with	ADP
iajs-3527	28	14	steady	steady	ADJ
iajs-3527	28	15	or	or	CCONJ
iajs-3527	28	16	changeable	changeable	ADJ
iajs-3527	28	17	myocardial	myocardial	ADJ
iajs-3527	28	18	infarction	infarction	NOUN
iajs-3527	28	19	(	(	PUNCT
iajs-3527	28	20	11	11	NUM
iajs-3527	28	21	)	)	PUNCT
iajs-3527	28	22	.	.	PUNCT
iajs-3527	29	1	tumor	tumor	NOUN
iajs-3527	29	2	necrosis	necrosis	NOUN
iajs-3527	29	3	factor	factor	NOUN
iajs-3527	29	4	-	-	PUNCT
iajs-3527	29	5	alpha	alpha	NOUN
iajs-3527	29	6	(	(	PUNCT
iajs-3527	29	7	tnf	tnf	PROPN
iajs-3527	29	8	-	-	PUNCT
iajs-3527	29	9	alpha	alpha	NOUN
iajs-3527	29	10	)	)	PUNCT
iajs-3527	29	11	is	be	AUX
iajs-3527	29	12	formed	form	VERB
iajs-3527	29	13	by	by	ADP
iajs-3527	29	14	mononuclear	mononuclear	ADJ
iajs-3527	29	15	phagocytic	phagocytic	ADJ
iajs-3527	29	16	cells	cell	NOUN
iajs-3527	29	17	as	as	ADP
iajs-3527	29	18	incitation	incitation	NOUN
iajs-3527	29	19	for	for	ADP
iajs-3527	29	20	inflammation	inflammation	NOUN
iajs-3527	29	21	(	(	PUNCT
iajs-3527	29	22	12	12	NUM
iajs-3527	29	23	)	)	PUNCT
iajs-3527	29	24	.	.	PUNCT
iajs-3527	30	1	additionally	additionally	ADV
iajs-3527	30	2	,	,	PUNCT
iajs-3527	30	3	tnf	tnf	PROPN
iajs-3527	30	4	-	-	PUNCT
iajs-3527	30	5	alpha	alpha	NOUN
iajs-3527	30	6	is	be	AUX
iajs-3527	30	7	considered	consider	VERB
iajs-3527	30	8	a	a	DET
iajs-3527	30	9	strong	strong	ADJ
iajs-3527	30	10	promoter	promoter	NOUN
iajs-3527	30	11	for	for	ADP
iajs-3527	30	12	pro	pro	ADJ
iajs-3527	30	13	-	-	ADJ
iajs-3527	30	14	inflammatory	inflammatory	ADJ
iajs-3527	30	15	cytokines	cytokine	NOUN
iajs-3527	30	16	and	and	CCONJ
iajs-3527	30	17	chemokines	chemokine	NOUN
iajs-3527	30	18	(	(	PUNCT
iajs-3527	30	19	13	13	NUM
iajs-3527	30	20	)	)	PUNCT
iajs-3527	30	21	.	.	PUNCT
iajs-3527	31	1	also	also	ADV
iajs-3527	31	2	,	,	PUNCT
iajs-3527	31	3	inflammation	inflammation	NOUN
iajs-3527	31	4	has	have	AUX
iajs-3527	31	5	been	be	AUX
iajs-3527	31	6	recognized	recognize	VERB
iajs-3527	31	7	to	to	PART
iajs-3527	31	8	have	have	VERB
iajs-3527	31	9	an	an	DET
iajs-3527	31	10	essential	essential	ADJ
iajs-3527	31	11	role	role	NOUN
iajs-3527	31	12	in	in	ADP
iajs-3527	31	13	the	the	DET
iajs-3527	31	14	pathogenesis	pathogenesis	NOUN
iajs-3527	31	15	processes	process	NOUN
iajs-3527	31	16	of	of	ADP
iajs-3527	31	17	hypertension	hypertension	NOUN
iajs-3527	31	18	(	(	PUNCT
iajs-3527	31	19	14	14	NUM
iajs-3527	31	20	)	)	PUNCT
iajs-3527	31	21	.	.	PUNCT
iajs-3527	32	1	the	the	DET
iajs-3527	32	2	reason	reason	NOUN
iajs-3527	32	3	for	for	ADP
iajs-3527	32	4	this	this	DET
iajs-3527	32	5	paper	paper	NOUN
iajs-3527	32	6	is	be	AUX
iajs-3527	32	7	to	to	PART
iajs-3527	32	8	investigate	investigate	VERB
iajs-3527	32	9	the	the	DET
iajs-3527	32	10	alternation	alternation	NOUN
iajs-3527	32	11	in	in	ADP
iajs-3527	32	12	some	some	DET
iajs-3527	32	13	inflammatory	inflammatory	ADJ
iajs-3527	32	14	parameters	parameter	NOUN
iajs-3527	32	15	and	and	CCONJ
iajs-3527	32	16	tnf	tnf	PROPN
iajs-3527	32	17	-	-	PUNCT
iajs-3527	32	18	alpha	alpha	NOUN
iajs-3527	32	19	in	in	ADP
iajs-3527	32	20	both	both	CCONJ
iajs-3527	32	21	healthy	healthy	ADJ
iajs-3527	32	22	and	and	CCONJ
iajs-3527	32	23	patient	patient	ADJ
iajs-3527	32	24	women	woman	NOUN
iajs-3527	32	25	with	with	ADP
iajs-3527	32	26	hypertension	hypertension	NOUN
iajs-3527	32	27	.	.	PUNCT
iajs-3527	33	1	2	2	X
iajs-3527	33	2	.	.	X
iajs-3527	33	3	material	material	NOUN
iajs-3527	33	4	and	and	CCONJ
iajs-3527	33	5	methods	method	NOUN
iajs-3527	33	6	2.1	2.1	NUM
iajs-3527	33	7	.	.	PUNCT
iajs-3527	34	1	experimental	experimental	ADJ
iajs-3527	34	2	design	design	NOUN
iajs-3527	34	3	ninety	ninety	NUM
iajs-3527	34	4	postmenopausal	postmenopausal	ADJ
iajs-3527	34	5	women	woman	NOUN
iajs-3527	34	6	aged	age	VERB
iajs-3527	34	7	between	between	ADP
iajs-3527	34	8	53	53	NUM
iajs-3527	34	9	and	and	CCONJ
iajs-3527	34	10	70	70	NUM
iajs-3527	34	11	years	year	NOUN
iajs-3527	34	12	at	at	ADP
iajs-3527	34	13	baghdad	baghdad	PROPN
iajs-3527	34	14	teaching	teaching	NOUN
iajs-3527	34	15	hospital	hospital	NOUN
iajs-3527	34	16	,	,	PUNCT
iajs-3527	34	17	laboratories	laboratory	NOUN
iajs-3527	34	18	were	be	AUX
iajs-3527	34	19	chosen	choose	VERB
iajs-3527	34	20	for	for	ADP
iajs-3527	34	21	our	our	PRON
iajs-3527	34	22	trials	trial	NOUN
iajs-3527	34	23	,	,	PUNCT
iajs-3527	34	24	which	which	PRON
iajs-3527	34	25	were	be	AUX
iajs-3527	34	26	divided	divide	VERB
iajs-3527	34	27	into	into	ADP
iajs-3527	34	28	two	two	NUM
iajs-3527	34	29	studied	study	VERB
iajs-3527	34	30	groups	group	NOUN
iajs-3527	34	31	:	:	PUNCT
iajs-3527	34	32	one	one	NUM
iajs-3527	34	33	had	have	VERB
iajs-3527	34	34	sixty	sixty	NUM
iajs-3527	34	35	women	woman	NOUN
iajs-3527	34	36	with	with	ADP
iajs-3527	34	37	hypertension	hypertension	NOUN
iajs-3527	34	38	,	,	PUNCT
iajs-3527	34	39	in	in	ADP
iajs-3527	34	40	addition	addition	NOUN
iajs-3527	34	41	to	to	ADP
iajs-3527	34	42	thirty	thirty	NUM
iajs-3527	34	43	healthy	healthy	ADJ
iajs-3527	34	44	women	woman	NOUN
iajs-3527	34	45	.	.	PUNCT
iajs-3527	35	1	2.2	2.2	NUM
iajs-3527	35	2	.	.	PUNCT
iajs-3527	35	3	collection	collection	NOUN
iajs-3527	35	4	of	of	ADP
iajs-3527	35	5	blood	blood	NOUN
iajs-3527	35	6	trials	trial	NOUN
iajs-3527	35	7	venous	venous	ADJ
iajs-3527	35	8	blood	blood	NOUN
iajs-3527	35	9	was	be	AUX
iajs-3527	35	10	taken	take	VERB
iajs-3527	35	11	from	from	ADP
iajs-3527	35	12	women	woman	NOUN
iajs-3527	35	13	of	of	ADP
iajs-3527	35	14	experimental	experimental	ADJ
iajs-3527	35	15	groups	group	NOUN
iajs-3527	35	16	by	by	ADP
iajs-3527	35	17	syringes	syrinx	NOUN
iajs-3527	35	18	into	into	ADP
iajs-3527	35	19	gel	gel	NOUN
iajs-3527	35	20	tubes	tube	NOUN
iajs-3527	35	21	.	.	PUNCT
iajs-3527	36	1	blood	blood	NOUN
iajs-3527	36	2	serum	serum	NOUN
iajs-3527	36	3	was	be	AUX
iajs-3527	36	4	obtained	obtain	VERB
iajs-3527	36	5	after	after	ADP
iajs-3527	36	6	allowing	allow	VERB
iajs-3527	36	7	the	the	DET
iajs-3527	36	8	blood	blood	NOUN
iajs-3527	36	9	to	to	PART
iajs-3527	36	10	clot	clot	VERB
iajs-3527	36	11	in	in	ADP
iajs-3527	36	12	the	the	DET
iajs-3527	36	13	tube	tube	NOUN
iajs-3527	36	14	without	without	ADP
iajs-3527	36	15	anticoagulant	anticoagulant	NOUN
iajs-3527	36	16	for	for	ADP
iajs-3527	36	17	10	10	NUM
iajs-3527	36	18	-	-	SYM
iajs-3527	36	19	20	20	NUM
iajs-3527	36	20	min	min	NOUN
iajs-3527	36	21	at	at	ADP
iajs-3527	36	22	room	room	NOUN
iajs-3527	36	23	temperature	temperature	NOUN
iajs-3527	36	24	.	.	PUNCT
iajs-3527	37	1	to	to	PART
iajs-3527	37	2	calculate	calculate	VERB
iajs-3527	37	3	(	(	PUNCT
iajs-3527	37	4	tnf	tnf	PROPN
iajs-3527	37	5	-	-	PUNCT
iajs-3527	37	6	alpha	alpha	PROPN
iajs-3527	37	7	,	,	PUNCT
iajs-3527	37	8	crp	crp	PROPN
iajs-3527	37	9	)	)	PUNCT
iajs-3527	37	10	for	for	ADP
iajs-3527	37	11	all	all	DET
iajs-3527	37	12	samples	sample	NOUN
iajs-3527	37	13	,	,	PUNCT
iajs-3527	37	14	serum	serum	NOUN
iajs-3527	37	15	separation	separation	NOUN
iajs-3527	37	16	was	be	AUX
iajs-3527	37	17	done	do	VERB
iajs-3527	37	18	by	by	ADP
iajs-3527	37	19	centrifuge	centrifuge	NOUN
iajs-3527	37	20	machine	machine	NOUN
iajs-3527	37	21	at	at	ADP
iajs-3527	37	22	3000	3000	NUM
iajs-3527	37	23	rpm	rpm	NOUN
iajs-3527	37	24	for	for	ADP
iajs-3527	37	25	five	five	NUM
iajs-3527	37	26	minutes	minute	NOUN
iajs-3527	37	27	.	.	PUNCT
iajs-3527	38	1	2.3	2.3	NUM
iajs-3527	38	2	.	.	PUNCT
iajs-3527	39	1	hematological	hematological	ADJ
iajs-3527	39	2	test	test	NOUN
iajs-3527	39	3	(	(	PUNCT
iajs-3527	39	4	cbc	cbc	PROPN
iajs-3527	39	5	,	,	PUNCT
iajs-3527	39	6	esr	esr	PROPN
iajs-3527	39	7	)	)	PUNCT
iajs-3527	39	8	venous	venous	ADJ
iajs-3527	39	9	blood	blood	NOUN
iajs-3527	39	10	was	be	AUX
iajs-3527	39	11	collected	collect	VERB
iajs-3527	39	12	in	in	ADP
iajs-3527	39	13	to	to	ADP
iajs-3527	39	14	edta	edta	NOUN
iajs-3527	39	15	tube	tube	NOUN
iajs-3527	39	16	with	with	ADP
iajs-3527	39	17	anticoagulant	anticoagulant	NOUN
iajs-3527	39	18	.	.	PUNCT
iajs-3527	40	1	for	for	ADP
iajs-3527	40	2	complete	complete	ADJ
iajs-3527	40	3	blood	blood	NOUN
iajs-3527	40	4	count	count	NOUN
iajs-3527	40	5	cbc	cbc	NOUN
iajs-3527	40	6	putting	put	VERB
iajs-3527	40	7	the	the	DET
iajs-3527	40	8	tube	tube	NOUN
iajs-3527	40	9	on	on	ADP
iajs-3527	40	10	roll	roll	NOUN
iajs-3527	40	11	mixer	mixer	NOUN
iajs-3527	40	12	for	for	ADP
iajs-3527	40	13	2	2	NUM
iajs-3527	40	14	minutes	minute	NOUN
iajs-3527	40	15	then	then	ADV
iajs-3527	40	16	the	the	DET
iajs-3527	40	17	results	result	NOUN
iajs-3527	40	18	will	will	AUX
iajs-3527	40	19	appear	appear	VERB
iajs-3527	40	20	on	on	ADP
iajs-3527	40	21	screen	screen	NOUN
iajs-3527	40	22	of	of	ADP
iajs-3527	40	23	hematology	hematology	NOUN
iajs-3527	40	24	analyzer	analyzer	NOUN
iajs-3527	40	25	,	,	PUNCT
iajs-3527	40	26	while	while	SCONJ
iajs-3527	40	27	erythrocyte	erythrocyte	PROPN
iajs-3527	40	28	sedimentation	sedimentation	NOUN
iajs-3527	40	29	rate	rate	NOUN
iajs-3527	40	30	(	(	PUNCT
iajs-3527	40	31	esr	esr	NOUN
iajs-3527	40	32	)	)	PUNCT
iajs-3527	40	33	blood	blood	NOUN
iajs-3527	40	34	drained	drain	VERB
iajs-3527	40	35	into	into	ADP
iajs-3527	40	36	esr	esr	PROPN
iajs-3527	40	37	tube	tube	NOUN
iajs-3527	40	38	and	and	CCONJ
iajs-3527	40	39	hold	hold	VERB
iajs-3527	40	40	it	it	PRON
iajs-3527	40	41	to	to	ADP
iajs-3527	40	42	esr	esr	PROPN
iajs-3527	40	43	detector	detector	NOUN
iajs-3527	40	44	the	the	DET
iajs-3527	40	45	ratio	ratio	NOUN
iajs-3527	40	46	of	of	ADP
iajs-3527	40	47	rbcs	rbc	NOUN
iajs-3527	40	48	falling	fall	VERB
iajs-3527	40	49	out	out	ADP
iajs-3527	40	50	of	of	ADP
iajs-3527	40	51	plasma	plasma	NOUN
iajs-3527	40	52	after	after	ADP
iajs-3527	40	53	one	one	NUM
iajs-3527	40	54	hour	hour	NOUN
iajs-3527	40	55	,	,	PUNCT
iajs-3527	40	56	then	then	ADV
iajs-3527	40	57	read	read	VERB
iajs-3527	40	58	the	the	DET
iajs-3527	40	59	result	result	NOUN
iajs-3527	40	60	in	in	ADP
iajs-3527	40	61	millimeter	millimeter	NOUN
iajs-3527	40	62	per	per	ADP
iajs-3527	40	63	hour	hour	NOUN
iajs-3527	40	64	(	(	PUNCT
iajs-3527	40	65	mm	mm	PROPN
iajs-3527	40	66	/	/	SYM
iajs-3527	40	67	h	h	NOUN
iajs-3527	40	68	)	)	PUNCT
iajs-3527	40	69	.	.	PUNCT
iajs-3527	41	1	2.4	2.4	NUM
iajs-3527	41	2	.	.	PUNCT
iajs-3527	42	1	biochemical	biochemical	ADJ
iajs-3527	42	2	test	test	NOUN
iajs-3527	42	3	c	c	NOUN
iajs-3527	42	4	-	-	PUNCT
iajs-3527	42	5	reactive	reactive	ADJ
iajs-3527	42	6	protein	protein	NOUN
iajs-3527	42	7	(	(	PUNCT
iajs-3527	42	8	crp	crp	NOUN
iajs-3527	42	9	)	)	PUNCT
iajs-3527	42	10	kit	kit	NOUN
iajs-3527	42	11	and	and	CCONJ
iajs-3527	42	12	(	(	PUNCT
iajs-3527	42	13	tnf	tnf	PROPN
iajs-3527	42	14	-	-	PUNCT
iajs-3527	42	15	alpha	alpha	NOUN
iajs-3527	42	16	)	)	PUNCT
iajs-3527	42	17	kit	kit	NOUN
iajs-3527	42	18	by	by	ADP
iajs-3527	42	19	using	use	VERB
iajs-3527	42	20	the	the	DET
iajs-3527	42	21	(	(	PUNCT
iajs-3527	42	22	elisa	elisa	NOUN
iajs-3527	42	23	technique	technique	NOUN
iajs-3527	42	24	,	,	PUNCT
iajs-3527	42	25	according	accord	VERB
iajs-3527	42	26	to	to	ADP
iajs-3527	42	27	the	the	DET
iajs-3527	42	28	manufacturer	manufacturer	NOUN
iajs-3527	42	29	's	's	PART
iajs-3527	42	30	instructions	instruction	NOUN
iajs-3527	42	31	of	of	ADP
iajs-3527	42	32	my	my	PRON
iajs-3527	42	33	bio	bio	NOUN
iajs-3527	42	34	source	source	PROPN
iajs-3527	42	35	usa	usa	PROPN
iajs-3527	42	36	kit	kit	PROPN
iajs-3527	42	37	.	.	PROPN
iajs-3527	43	1	2.5	2.5	NUM
iajs-3527	43	2	.	.	PUNCT
iajs-3527	44	1	statistical	statistical	ADJ
iajs-3527	44	2	analysis	analysis	NOUN
iajs-3527	44	3	the	the	DET
iajs-3527	44	4	statistical	statistical	ADJ
iajs-3527	44	5	analysis	analysis	NOUN
iajs-3527	44	6	system	system	NOUN
iajs-3527	44	7	—	—	PUNCT
iajs-3527	44	8	sas	sas	PROPN
iajs-3527	44	9	(	(	PUNCT
iajs-3527	44	10	2018	2018	NUM
iajs-3527	44	11	)	)	PUNCT
iajs-3527	44	12	program	program	NOUN
iajs-3527	44	13	was	be	AUX
iajs-3527	44	14	used	use	VERB
iajs-3527	44	15	to	to	PART
iajs-3527	44	16	detect	detect	VERB
iajs-3527	44	17	the	the	DET
iajs-3527	44	18	effect	effect	NOUN
iajs-3527	44	19	of	of	ADP
iajs-3527	44	20	different	different	ADJ
iajs-3527	44	21	groups	group	NOUN
iajs-3527	44	22	(	(	PUNCT
iajs-3527	44	23	patients	patient	NOUN
iajs-3527	44	24	and	and	CCONJ
iajs-3527	44	25	control	control	NOUN
iajs-3527	44	26	)	)	PUNCT
iajs-3527	44	27	in	in	ADP
iajs-3527	44	28	study	study	NOUN
iajs-3527	44	29	parameters	parameter	NOUN
iajs-3527	44	30	.	.	PUNCT
iajs-3527	45	1	a	a	DET
iajs-3527	45	2	t	t	NOUN
iajs-3527	45	3	-	-	PUNCT
iajs-3527	45	4	test	test	NOUN
iajs-3527	45	5	was	be	AUX
iajs-3527	45	6	used	use	VERB
iajs-3527	45	7	to	to	PART
iajs-3527	45	8	significantly	significantly	ADV
iajs-3527	45	9	compare	compare	VERB
iajs-3527	45	10	between	between	ADP
iajs-3527	45	11	means	mean	NOUN
iajs-3527	45	12	.	.	PUNCT
iajs-3527	46	1	3	3	X
iajs-3527	46	2	.	.	NOUN
iajs-3527	46	3	results	result	VERB
iajs-3527	46	4	results	result	NOUN
iajs-3527	46	5	of	of	ADP
iajs-3527	46	6	the	the	DET
iajs-3527	46	7	study	study	NOUN
iajs-3527	46	8	showed	show	VERB
iajs-3527	46	9	that	that	SCONJ
iajs-3527	46	10	there	there	PRON
iajs-3527	46	11	was	be	VERB
iajs-3527	46	12	no	no	DET
iajs-3527	46	13	significant	significant	ADJ
iajs-3527	46	14	variation	variation	NOUN
iajs-3527	46	15	in	in	ADP
iajs-3527	46	16	age	age	NOUN
iajs-3527	46	17	(	(	PUNCT
iajs-3527	46	18	t	t	NOUN
iajs-3527	46	19	-	-	PUNCT
iajs-3527	46	20	test	test	NOUN
iajs-3527	46	21	)	)	PUNCT
iajs-3527	46	22	value	value	NOUN
iajs-3527	46	23	(	(	PUNCT
iajs-3527	46	24	2.348	2.348	NUM
iajs-3527	46	25	)	)	PUNCT
iajs-3527	46	26	in	in	ADP
iajs-3527	46	27	postmenopausal	postmenopausal	ADJ
iajs-3527	46	28	women	woman	NOUN
iajs-3527	46	29	in	in	ADP
iajs-3527	46	30	the	the	DET
iajs-3527	46	31	mean	mean	NOUN
iajs-3527	46	32	of	of	ADP
iajs-3527	46	33	patients	patient	NOUN
iajs-3527	46	34	(	(	PUNCT
iajs-3527	46	35	59.45±0.68	59.45±0.68	NUM
iajs-3527	46	36	)	)	PUNCT
iajs-3527	46	37	years	year	NOUN
iajs-3527	46	38	,	,	PUNCT
iajs-3527	46	39	while	while	SCONJ
iajs-3527	46	40	healthy	healthy	ADJ
iajs-3527	46	41	ihjpas	ihjpa	NOUN
iajs-3527	46	42	.	.	PUNCT
iajs-3527	47	1	2025	2025	NUM
iajs-3527	47	2	,	,	PUNCT
iajs-3527	47	3	38(3	38(3	NUM
iajs-3527	47	4	)	)	PUNCT
iajs-3527	47	5	9	9	NUM
iajs-3527	47	6	women	woman	NOUN
iajs-3527	47	7	were	be	AUX
iajs-3527	47	8	(	(	PUNCT
iajs-3527	47	9	57.50±0.97	57.50±0.97	PROPN
iajs-3527	47	10	)	)	PUNCT
iajs-3527	47	11	.	.	PUNCT
iajs-3527	48	1	there	there	PRON
iajs-3527	48	2	were	be	VERB
iajs-3527	48	3	significant	significant	ADJ
iajs-3527	48	4	changes	change	NOUN
iajs-3527	48	5	in	in	ADP
iajs-3527	48	6	body	body	NOUN
iajs-3527	48	7	mass	mass	NOUN
iajs-3527	48	8	index	index	NOUN
iajs-3527	48	9	(	(	PUNCT
iajs-3527	48	10	bmi	bmi	PROPN
iajs-3527	48	11	)	)	PUNCT
iajs-3527	48	12	in	in	ADP
iajs-3527	48	13	postmenopausal	postmenopausal	ADJ
iajs-3527	48	14	women	woman	NOUN
iajs-3527	48	15	(	(	PUNCT
iajs-3527	48	16	p≤0.01	p≤0.01	NOUN
iajs-3527	48	17	)	)	PUNCT
iajs-3527	48	18	that	that	PRON
iajs-3527	48	19	were	be	AUX
iajs-3527	48	20	found	find	VERB
iajs-3527	48	21	between	between	ADP
iajs-3527	48	22	the	the	DET
iajs-3527	48	23	mean	mean	NOUN
iajs-3527	48	24	of	of	ADP
iajs-3527	48	25	patients	patient	NOUN
iajs-3527	48	26	(	(	PUNCT
iajs-3527	48	27	28.19±0.59	28.19±0.59	NUM
iajs-3527	48	28	)	)	PUNCT
iajs-3527	48	29	and	and	CCONJ
iajs-3527	48	30	the	the	DET
iajs-3527	48	31	control	control	NOUN
iajs-3527	48	32	group	group	NOUN
iajs-3527	48	33	(	(	PUNCT
iajs-3527	48	34	25.65±0.19	25.65±0.19	NUM
iajs-3527	48	35	)	)	PUNCT
iajs-3527	48	36	.	.	PUNCT
iajs-3527	49	1	also	also	ADV
iajs-3527	49	2	,	,	PUNCT
iajs-3527	49	3	there	there	PRON
iajs-3527	49	4	were	be	VERB
iajs-3527	49	5	significant	significant	ADJ
iajs-3527	49	6	changes	change	NOUN
iajs-3527	49	7	(	(	PUNCT
iajs-3527	49	8	p≤0.01	p≤0.01	NOUN
iajs-3527	49	9	)	)	PUNCT
iajs-3527	49	10	in	in	ADP
iajs-3527	49	11	the	the	DET
iajs-3527	49	12	mean	mean	ADJ
iajs-3527	49	13	values	value	NOUN
iajs-3527	49	14	of	of	ADP
iajs-3527	49	15	blood	blood	NOUN
iajs-3527	49	16	pressure	pressure	NOUN
iajs-3527	49	17	diastole	diastole	NOUN
iajs-3527	49	18	(	(	PUNCT
iajs-3527	49	19	8.76±0.06	8.76±0.06	NUM
iajs-3527	49	20	)	)	PUNCT
iajs-3527	49	21	and	and	CCONJ
iajs-3527	49	22	systole	systole	PROPN
iajs-3527	49	23	(	(	PUNCT
iajs-3527	49	24	16.00±0.15	16.00±0.15	NUM
iajs-3527	49	25	)	)	PUNCT
iajs-3527	49	26	in	in	ADP
iajs-3527	49	27	postmenopausal	postmenopausal	ADJ
iajs-3527	49	28	women	woman	NOUN
iajs-3527	49	29	compared	compare	VERB
iajs-3527	49	30	with	with	ADP
iajs-3527	49	31	the	the	DET
iajs-3527	49	32	control	control	NOUN
iajs-3527	49	33	group	group	NOUN
iajs-3527	49	34	with	with	ADP
iajs-3527	49	35	mean	mean	ADJ
iajs-3527	49	36	values	value	NOUN
iajs-3527	49	37	(	(	PUNCT
iajs-3527	49	38	7.73±0.12	7.73±0.12	NOUN
iajs-3527	49	39	)	)	PUNCT
iajs-3527	49	40	and	and	CCONJ
iajs-3527	49	41	(	(	PUNCT
iajs-3527	49	42	11.60±0.14	11.60±0.14	NUM
iajs-3527	49	43	)	)	PUNCT
iajs-3527	49	44	,	,	PUNCT
iajs-3527	49	45	sequentially	sequentially	ADV
iajs-3527	49	46	.	.	PUNCT
iajs-3527	50	1	significant	significant	ADJ
iajs-3527	50	2	difference	difference	NOUN
iajs-3527	50	3	(	(	PUNCT
iajs-3527	50	4	p≤	p≤	NOUN
iajs-3527	50	5	0.01	0.01	NUM
iajs-3527	50	6	)	)	PUNCT
iajs-3527	50	7	in	in	ADP
iajs-3527	50	8	mean	mean	ADJ
iajs-3527	50	9	value	value	NOUN
iajs-3527	50	10	of	of	ADP
iajs-3527	50	11	hb	hb	PROPN
iajs-3527	50	12	patient	patient	ADJ
iajs-3527	50	13	women	woman	NOUN
iajs-3527	50	14	(	(	PUNCT
iajs-3527	50	15	12.89	12.89	NUM
iajs-3527	50	16	±	±	NUM
iajs-3527	50	17	0.16	0.16	NUM
iajs-3527	50	18	)	)	PUNCT
iajs-3527	50	19	as	as	ADP
iajs-3527	50	20	compared	compare	VERB
iajs-3527	50	21	with	with	ADP
iajs-3527	50	22	healthy	healthy	ADJ
iajs-3527	50	23	women	woman	NOUN
iajs-3527	50	24	(	(	PUNCT
iajs-3527	50	25	12.32±0.24	12.32±0.24	NUM
iajs-3527	50	26	)	)	PUNCT
iajs-3527	50	27	.	.	PUNCT
iajs-3527	51	1	no	no	DET
iajs-3527	51	2	significant	significant	ADJ
iajs-3527	51	3	changes	change	NOUN
iajs-3527	51	4	in	in	ADP
iajs-3527	51	5	mean	mean	ADJ
iajs-3527	51	6	value	value	NOUN
iajs-3527	51	7	of	of	ADP
iajs-3527	51	8	platelets	platelet	NOUN
iajs-3527	51	9	(	(	PUNCT
iajs-3527	51	10	253.90±970	253.90±970	NUM
iajs-3527	51	11	)	)	PUNCT
iajs-3527	51	12	and	and	CCONJ
iajs-3527	51	13	wbcs	wbc	NOUN
iajs-3527	51	14	(	(	PUNCT
iajs-3527	51	15	7.97±0.39	7.97±0.39	NOUN
iajs-3527	51	16	)	)	PUNCT
iajs-3527	51	17	in	in	ADP
iajs-3527	51	18	patient	patient	ADJ
iajs-3527	51	19	postmenopausal	postmenopausal	ADJ
iajs-3527	51	20	women	woman	NOUN
iajs-3527	51	21	with	with	ADP
iajs-3527	51	22	control	control	NOUN
iajs-3527	51	23	group	group	NOUN
iajs-3527	51	24	value	value	NOUN
iajs-3527	51	25	(	(	PUNCT
iajs-3527	51	26	251±12.34	251±12.34	NUM
iajs-3527	51	27	)	)	PUNCT
iajs-3527	51	28	and	and	CCONJ
iajs-3527	51	29	(	(	PUNCT
iajs-3527	51	30	7.87±0.32	7.87±0.32	NUM
iajs-3527	51	31	)	)	PUNCT
iajs-3527	51	32	,	,	PUNCT
iajs-3527	51	33	respectively	respectively	ADV
iajs-3527	51	34	.	.	PUNCT
iajs-3527	52	1	significant	significant	ADJ
iajs-3527	52	2	change	change	NOUN
iajs-3527	52	3	(	(	PUNCT
iajs-3527	52	4	p≤0.01	p≤0.01	NOUN
iajs-3527	52	5	)	)	PUNCT
iajs-3527	52	6	in	in	ADP
iajs-3527	52	7	mean	mean	ADJ
iajs-3527	52	8	value	value	NOUN
iajs-3527	52	9	of	of	ADP
iajs-3527	52	10	tnf	tnf	PROPN
iajs-3527	52	11	-	-	PUNCT
iajs-3527	52	12	alpha	alpha	NOUN
iajs-3527	52	13	patient	patient	ADJ
iajs-3527	52	14	women	woman	NOUN
iajs-3527	52	15	(	(	PUNCT
iajs-3527	52	16	146.79±4.45	146.79±4.45	NUM
iajs-3527	52	17	)	)	PUNCT
iajs-3527	52	18	as	as	SCONJ
iajs-3527	52	19	compared	compare	VERB
iajs-3527	52	20	with	with	ADP
iajs-3527	52	21	control	control	NOUN
iajs-3527	52	22	(	(	PUNCT
iajs-3527	52	23	66.13	66.13	NUM
iajs-3527	52	24	±	±	NUM
iajs-3527	52	25	1.32	1.32	NUM
iajs-3527	52	26	)	)	PUNCT
iajs-3527	52	27	.	.	PUNCT
iajs-3527	53	1	c	c	X
iajs-3527	53	2	-	-	PUNCT
iajs-3527	53	3	reactive	reactive	ADJ
iajs-3527	53	4	protein	protein	NOUN
iajs-3527	53	5	crp	crp	PROPN
iajs-3527	53	6	results	result	NOUN
iajs-3527	53	7	showed	show	VERB
iajs-3527	53	8	a	a	DET
iajs-3527	53	9	significant	significant	ADJ
iajs-3527	53	10	difference	difference	NOUN
iajs-3527	53	11	(	(	PUNCT
iajs-3527	53	12	p	p	NOUN
iajs-3527	53	13	≤	≤	NOUN
iajs-3527	53	14	0.01	0.01	NUM
iajs-3527	53	15	)	)	PUNCT
iajs-3527	53	16	in	in	ADP
iajs-3527	53	17	mean	mean	ADJ
iajs-3527	53	18	value	value	NOUN
iajs-3527	53	19	,	,	PUNCT
iajs-3527	53	20	with	with	ADP
iajs-3527	53	21	patients	patient	NOUN
iajs-3527	53	22	being	be	AUX
iajs-3527	53	23	women	woman	NOUN
iajs-3527	53	24	(	(	PUNCT
iajs-3527	53	25	2.37±0.10	2.37±0.10	NOUN
iajs-3527	53	26	)	)	PUNCT
iajs-3527	53	27	while	while	SCONJ
iajs-3527	53	28	the	the	DET
iajs-3527	53	29	control	control	NOUN
iajs-3527	53	30	group	group	NOUN
iajs-3527	53	31	was	be	AUX
iajs-3527	53	32	(	(	PUNCT
iajs-3527	53	33	0.813±0.04	0.813±0.04	NUM
iajs-3527	53	34	)	)	PUNCT
iajs-3527	53	35	.	.	PUNCT
iajs-3527	54	1	there	there	PRON
iajs-3527	54	2	was	be	VERB
iajs-3527	54	3	no	no	DET
iajs-3527	54	4	significant	significant	ADJ
iajs-3527	54	5	change	change	NOUN
iajs-3527	54	6	in	in	ADP
iajs-3527	54	7	the	the	DET
iajs-3527	54	8	esr	esr	PROPN
iajs-3527	54	9	mean	mean	NOUN
iajs-3527	54	10	of	of	ADP
iajs-3527	54	11	patients	patient	NOUN
iajs-3527	54	12	who	who	PRON
iajs-3527	54	13	were	be	AUX
iajs-3527	54	14	women	woman	NOUN
iajs-3527	54	15	(	(	PUNCT
iajs-3527	54	16	34.31	34.31	NUM
iajs-3527	54	17	±	±	NUM
iajs-3527	54	18	3.02	3.02	NUM
iajs-3527	54	19	)	)	PUNCT
iajs-3527	54	20	and	and	CCONJ
iajs-3527	54	21	the	the	DET
iajs-3527	54	22	control	control	NOUN
iajs-3527	54	23	group	group	NOUN
iajs-3527	54	24	(	(	PUNCT
iajs-3527	54	25	31.40	31.40	NUM
iajs-3527	54	26	±	±	NUM
iajs-3527	54	27	3.02	3.02	NUM
iajs-3527	54	28	)	)	PUNCT
iajs-3527	54	29	,	,	PUNCT
iajs-3527	54	30	as	as	SCONJ
iajs-3527	54	31	shown	show	VERB
iajs-3527	54	32	in	in	ADP
iajs-3527	54	33	tables	table	NOUN
iajs-3527	54	34	(	(	PUNCT
iajs-3527	54	35	1	1	NUM
iajs-3527	54	36	)	)	PUNCT
iajs-3527	54	37	and	and	CCONJ
iajs-3527	54	38	(	(	PUNCT
iajs-3527	54	39	2	2	NUM
iajs-3527	54	40	)	)	PUNCT
iajs-3527	54	41	,	,	PUNCT
iajs-3527	54	42	as	as	ADV
iajs-3527	54	43	well	well	ADV
iajs-3527	54	44	as	as	ADP
iajs-3527	54	45	figure	figure	NOUN
iajs-3527	54	46	(	(	PUNCT
iajs-3527	54	47	1	1	NUM
iajs-3527	54	48	)	)	PUNCT
iajs-3527	54	49	.	.	PUNCT
iajs-3527	55	1	table	table	NOUN
iajs-3527	55	2	1	1	NUM
iajs-3527	55	3	.	.	X
iajs-3527	55	4	level	level	NOUN
iajs-3527	55	5	of	of	ADP
iajs-3527	55	6	hb	hb	PROPN
iajs-3527	55	7	,	,	PUNCT
iajs-3527	55	8	plat	plat	NOUN
iajs-3527	55	9	and	and	CCONJ
iajs-3527	55	10	wbcs	wbc	VERB
iajs-3527	55	11	in	in	ADP
iajs-3527	55	12	studied	study	VERB
iajs-3527	55	13	groups	group	NOUN
iajs-3527	55	14	.	.	PUNCT
iajs-3527	56	1	mean	mean	VERB
iajs-3527	56	2	with	with	ADP
iajs-3527	56	3	different	different	ADJ
iajs-3527	56	4	letters	letter	NOUN
iajs-3527	56	5	in	in	ADP
iajs-3527	56	6	the	the	DET
iajs-3527	56	7	same	same	ADJ
iajs-3527	56	8	row	row	NOUN
iajs-3527	56	9	differs	differ	VERB
iajs-3527	56	10	significantly	significantly	ADV
iajs-3527	56	11	,	,	PUNCT
iajs-3527	56	12	*	*	PUNCT
iajs-3527	56	13	*	*	PUNCT
iajs-3527	56	14	(	(	PUNCT
iajs-3527	56	15	p≤0.01	p≤0.01	NOUN
iajs-3527	56	16	)	)	PUNCT
iajs-3527	56	17	table	table	NOUN
iajs-3527	56	18	2	2	NUM
iajs-3527	56	19	.	.	X
iajs-3527	56	20	level	level	NOUN
iajs-3527	56	21	of	of	ADP
iajs-3527	56	22	inflammatory	inflammatory	ADJ
iajs-3527	56	23	parameters	parameter	NOUN
iajs-3527	56	24	in	in	ADP
iajs-3527	56	25	studied	study	VERB
iajs-3527	56	26	groups	group	NOUN
iajs-3527	56	27	.	.	PUNCT
iajs-3527	57	1	ttest	tt	ADJ
iajs-3527	57	2	control	control	NOUN
iajs-3527	57	3	patients	patient	NOUN
iajs-3527	57	4	parameters	parameter	NOUN
iajs-3527	57	5	12.675	12.675	NUM
iajs-3527	57	6	*	*	NOUN
iajs-3527	57	7	*	*	PUNCT
iajs-3527	57	8	66.13±1.32b	66.13±1.32b	NUM
iajs-3527	57	9	146.79±4.45a	146.79±4.45a	NUM
iajs-3527	57	10	tnf	tnf	PROPN
iajs-3527	57	11	-	-	PUNCT
iajs-3527	57	12	alpha	alpha	NOUN
iajs-3527	57	13	(	(	PUNCT
iajs-3527	57	14	µg	µg	NOUN
iajs-3527	57	15	/	/	SYM
iajs-3527	57	16	ml	ml	NOUN
iajs-3527	57	17	)	)	PUNCT
iajs-3527	57	18	0.299	0.299	NUM
iajs-3527	57	19	*	*	SYM
iajs-3527	57	20	*	*	NOUN
iajs-3527	57	21	0.813±0.04a	0.813±0.04a	NUM
iajs-3527	57	22	2.37±0.10c	2.37±0.10c	NUM
iajs-3527	57	23	crp(mg	crp(mg	NOUN
iajs-3527	57	24	/	/	SYM
iajs-3527	57	25	l	l	NOUN
iajs-3527	57	26	)	)	PUNCT
iajs-3527	58	1	9.675ns	9.675ns	PROPN
iajs-3527	58	2	31.40±3.02	31.40±3.02	NUM
iajs-3527	58	3	34.31±3.02	34.31±3.02	NUM
iajs-3527	58	4	esr(mm	esr(mm	NOUN
iajs-3527	58	5	/	/	SYM
iajs-3527	58	6	h	h	NOUN
iajs-3527	58	7	)	)	PUNCT
iajs-3527	58	8	mean	mean	NOUN
iajs-3527	58	9	with	with	ADP
iajs-3527	58	10	different	different	ADJ
iajs-3527	58	11	letters	letter	NOUN
iajs-3527	58	12	in	in	ADP
iajs-3527	58	13	the	the	DET
iajs-3527	58	14	same	same	ADJ
iajs-3527	58	15	row	row	NOUN
iajs-3527	58	16	differs	differ	VERB
iajs-3527	58	17	significantly	significantly	ADV
iajs-3527	58	18	,	,	PUNCT
iajs-3527	58	19	*	*	PUNCT
iajs-3527	58	20	*	*	PUNCT
iajs-3527	58	21	(	(	PUNCT
iajs-3527	58	22	p≤0.01	p≤0.01	NOUN
iajs-3527	58	23	)	)	PUNCT
iajs-3527	58	24	.	.	PUNCT
iajs-3527	59	1	figure1	figure1	PROPN
iajs-3527	59	2	.	.	PUNCT
iajs-3527	60	1	levels	level	NOUN
iajs-3527	60	2	of	of	ADP
iajs-3527	60	3	inflammatory	inflammatory	ADJ
iajs-3527	60	4	parameters	parameter	NOUN
iajs-3527	60	5	in	in	ADP
iajs-3527	60	6	postmenopausal	postmenopausal	ADJ
iajs-3527	60	7	women	woman	NOUN
iajs-3527	60	8	with	with	ADP
iajs-3527	60	9	hypertension	hypertension	NOUN
iajs-3527	60	10	and	and	CCONJ
iajs-3527	60	11	control	control	NOUN
iajs-3527	60	12	group	group	NOUN
iajs-3527	60	13	.	.	PUNCT
iajs-3527	61	1	0	0	NUM
iajs-3527	62	1	20	20	NUM
iajs-3527	62	2	40	40	NUM
iajs-3527	62	3	60	60	NUM
iajs-3527	62	4	80	80	NUM
iajs-3527	62	5	100	100	NUM
iajs-3527	62	6	120	120	NUM
iajs-3527	62	7	140	140	NUM
iajs-3527	62	8	160	160	NUM
iajs-3527	62	9	tnf	tnf	PROPN
iajs-3527	62	10	-	-	PUNCT
iajs-3527	62	11	alpha(µg	alpha(µg	NOUN
iajs-3527	62	12	/	/	SYM
iajs-3527	62	13	ml	ml	NOUN
iajs-3527	62	14	)	)	PUNCT
iajs-3527	62	15	esr(mm	esr(mm	NOUN
iajs-3527	62	16	/	/	SYM
iajs-3527	62	17	h	h	NOUN
iajs-3527	62	18	)	)	PUNCT
iajs-3527	62	19	…	…	PUNCT
iajs-3527	62	20	crp(mg	crp(mg	PROPN
iajs-3527	62	21	/	/	SYM
iajs-3527	62	22	l	l	NOUN
iajs-3527	62	23	)	)	PUNCT
iajs-3527	62	24	patients	patient	NOUN
iajs-3527	62	25	control	control	VERB
iajs-3527	62	26	ttest	tt	ADJ
iajs-3527	62	27	control	control	NOUN
iajs-3527	62	28	patients	patient	NOUN
iajs-3527	62	29	parameters	parameter	NOUN
iajs-3527	62	30	2.348ns	2.348ns	NUM
iajs-3527	62	31	57.50±0.97	57.50±0.97	NUM
iajs-3527	62	32	59.45±0.68	59.45±0.68	PROPN
iajs-3527	62	33	age(years	age(year	NOUN
iajs-3527	62	34	)	)	PUNCT
iajs-3527	62	35	0.989	0.989	NUM
iajs-3527	62	36	*	*	PUNCT
iajs-3527	62	37	*	*	PUNCT
iajs-3527	62	38	28.19±0.59b	28.19±0.59b	NUM
iajs-3527	62	39	25.65±0.19a	25.65±0.19a	NUM
iajs-3527	62	40	bmi	bmi	NOUN
iajs-3527	62	41	(	(	PUNCT
iajs-3527	62	42	kg/	kg/	NOUN
iajs-3527	62	43	m²	m²	PROPN
iajs-3527	62	44	)	)	PUNCT
iajs-3527	62	45	0.253	0.253	NUM
iajs-3527	62	46	*	*	PUNCT
iajs-3527	62	47	*	*	PUNCT
iajs-3527	63	1	7.73±0.12c	7.73±0.12c	NUM
iajs-3527	63	2	8.76±0.06b	8.76±0.06b	NUM
iajs-3527	63	3	diastolic	diastolic	ADJ
iajs-3527	63	4	b.p(mmhg	b.p(mmhg	NOUN
iajs-3527	63	5	)	)	PUNCT
iajs-3527	63	6	0.476	0.476	NUM
iajs-3527	63	7	*	*	NOUN
iajs-3527	63	8	*	*	PUNCT
iajs-3527	63	9	11.60±0.14c	11.60±0.14c	NUM
iajs-3527	63	10	16.00±0.15a	16.00±0.15a	NUM
iajs-3527	63	11	systolic	systolic	ADJ
iajs-3527	63	12	b.p(mmhg	b.p(mmhg	PROPN
iajs-3527	63	13	)	)	PUNCT
iajs-3527	63	14	0.574	0.574	NUM
iajs-3527	63	15	*	*	PUNCT
iajs-3527	63	16	*	*	PUNCT
iajs-3527	64	1	12.32±0.24a	12.32±0.24a	NUM
iajs-3527	64	2	12.89±0.16b	12.89±0.16b	NUM
iajs-3527	64	3	hb(g	hb(g	PROPN
iajs-3527	64	4	/	/	SYM
iajs-3527	64	5	dl	dl	NOUN
iajs-3527	64	6	)	)	PUNCT
iajs-3527	64	7	32.328ns	32.328ns	NUM
iajs-3527	65	1	251±12.34	251±12.34	NUM
iajs-3527	65	2	253.90±9.70	253.90±9.70	NUM
iajs-3527	65	3	plt*109(cell	plt*109(cell	NOUN
iajs-3527	65	4	/	/	SYM
iajs-3527	65	5	cu³	cu³	NOUN
iajs-3527	65	6	)	)	PUNCT
iajs-3527	65	7	1.195ns	1.195ns	NUM
iajs-3527	65	8	7.87±0.32	7.87±0.32	ADJ
iajs-3527	65	9	7.97±0.39	7.97±0.39	PROPN
iajs-3527	65	10	wbcs*109(cell	wbcs*109(cell	PROPN
iajs-3527	65	11	/	/	SYM
iajs-3527	65	12	cu³	cu³	PROPN
iajs-3527	65	13	)	)	PUNCT
iajs-3527	65	14	ihjpas	ihjpas	PROPN
iajs-3527	65	15	.	.	PUNCT
iajs-3527	66	1	2025	2025	NUM
iajs-3527	66	2	,	,	PUNCT
iajs-3527	66	3	38(3	38(3	NUM
iajs-3527	66	4	)	)	PUNCT
iajs-3527	66	5	01	01	NUM
iajs-3527	66	6	4	4	NUM
iajs-3527	66	7	.	.	PUNCT
iajs-3527	66	8	discussion	discussion	NOUN
iajs-3527	66	9	females	female	NOUN
iajs-3527	66	10	were	be	AUX
iajs-3527	66	11	selected	select	VERB
iajs-3527	66	12	for	for	ADP
iajs-3527	66	13	this	this	DET
iajs-3527	66	14	study	study	NOUN
iajs-3527	66	15	because	because	SCONJ
iajs-3527	66	16	data	datum	NOUN
iajs-3527	66	17	show	show	VERB
iajs-3527	66	18	that	that	SCONJ
iajs-3527	66	19	women	woman	NOUN
iajs-3527	66	20	have	have	VERB
iajs-3527	66	21	an	an	DET
iajs-3527	66	22	increasing	increase	VERB
iajs-3527	66	23	rate	rate	NOUN
iajs-3527	66	24	of	of	ADP
iajs-3527	66	25	hypertension	hypertension	NOUN
iajs-3527	66	26	more	more	ADJ
iajs-3527	66	27	than	than	ADP
iajs-3527	66	28	men	man	NOUN
iajs-3527	66	29	(	(	PUNCT
iajs-3527	66	30	15	15	NUM
iajs-3527	66	31	,	,	PUNCT
iajs-3527	66	32	16	16	NUM
iajs-3527	66	33	)	)	PUNCT
iajs-3527	66	34	.	.	PUNCT
iajs-3527	67	1	older	old	ADJ
iajs-3527	67	2	women	woman	NOUN
iajs-3527	67	3	have	have	VERB
iajs-3527	67	4	elevated	elevate	VERB
iajs-3527	67	5	levels	level	NOUN
iajs-3527	67	6	of	of	ADP
iajs-3527	67	7	hypertension	hypertension	NOUN
iajs-3527	67	8	more	more	ADJ
iajs-3527	67	9	than	than	ADP
iajs-3527	67	10	younger	young	ADJ
iajs-3527	67	11	ones	one	NOUN
iajs-3527	67	12	(	(	PUNCT
iajs-3527	67	13	17	17	NUM
iajs-3527	67	14	,	,	PUNCT
iajs-3527	67	15	18	18	NUM
iajs-3527	67	16	)	)	PUNCT
iajs-3527	67	17	.	.	PUNCT
iajs-3527	68	1	hypertension	hypertension	NOUN
iajs-3527	68	2	has	have	VERB
iajs-3527	68	3	the	the	DET
iajs-3527	68	4	highest	high	ADJ
iajs-3527	68	5	rate	rate	NOUN
iajs-3527	68	6	in	in	ADP
iajs-3527	68	7	women	woman	NOUN
iajs-3527	68	8	aged	age	VERB
iajs-3527	68	9	sixty	sixty	NUM
iajs-3527	68	10	years	year	NOUN
iajs-3527	68	11	(	(	PUNCT
iajs-3527	68	12	19	19	NUM
iajs-3527	68	13	)	)	PUNCT
iajs-3527	68	14	.	.	PUNCT
iajs-3527	69	1	postmenopausal	postmenopausal	PROPN
iajs-3527	69	2	women	woman	NOUN
iajs-3527	69	3	with	with	ADP
iajs-3527	69	4	obesity	obesity	NOUN
iajs-3527	69	5	resulted	result	VERB
iajs-3527	69	6	in	in	ADP
iajs-3527	69	7	elevated	elevated	ADJ
iajs-3527	69	8	hypertension	hypertension	NOUN
iajs-3527	69	9	and	and	CCONJ
iajs-3527	69	10	other	other	ADJ
iajs-3527	69	11	diseases	disease	NOUN
iajs-3527	69	12	like	like	ADP
iajs-3527	69	13	coronary	coronary	ADJ
iajs-3527	69	14	artery	artery	NOUN
iajs-3527	69	15	disease	disease	NOUN
iajs-3527	69	16	and	and	CCONJ
iajs-3527	69	17	death	death	NOUN
iajs-3527	69	18	(	(	PUNCT
iajs-3527	69	19	7	7	NUM
iajs-3527	69	20	)	)	PUNCT
iajs-3527	69	21	.	.	PUNCT
iajs-3527	70	1	it	it	PRON
iajs-3527	70	2	has	have	AUX
iajs-3527	70	3	been	be	AUX
iajs-3527	70	4	noted	note	VERB
iajs-3527	70	5	that	that	SCONJ
iajs-3527	70	6	obesity	obesity	NOUN
iajs-3527	70	7	in	in	ADP
iajs-3527	70	8	women	woman	NOUN
iajs-3527	70	9	is	be	AUX
iajs-3527	70	10	considered	consider	VERB
iajs-3527	70	11	a	a	DET
iajs-3527	70	12	mark	mark	NOUN
iajs-3527	70	13	for	for	ADP
iajs-3527	70	14	hypertension	hypertension	NOUN
iajs-3527	70	15	(	(	PUNCT
iajs-3527	70	16	20	20	NUM
iajs-3527	70	17	)	)	PUNCT
iajs-3527	70	18	.	.	PUNCT
iajs-3527	71	1	positive	positive	ADJ
iajs-3527	71	2	relation	relation	NOUN
iajs-3527	71	3	between	between	ADP
iajs-3527	71	4	bmi	bmi	NOUN
iajs-3527	71	5	and	and	CCONJ
iajs-3527	71	6	body	body	NOUN
iajs-3527	71	7	fat	fat	ADJ
iajs-3527	71	8	in	in	ADP
iajs-3527	71	9	postmenopausal	postmenopausal	ADJ
iajs-3527	71	10	women	woman	NOUN
iajs-3527	71	11	(	(	PUNCT
iajs-3527	71	12	21	21	NUM
iajs-3527	71	13	)	)	PUNCT
iajs-3527	71	14	.	.	PUNCT
iajs-3527	72	1	postmenopausal	postmenopausal	PROPN
iajs-3527	72	2	women	woman	NOUN
iajs-3527	72	3	have	have	VERB
iajs-3527	72	4	more	more	ADJ
iajs-3527	72	5	chance	chance	NOUN
iajs-3527	72	6	of	of	ADP
iajs-3527	72	7	obesity	obesity	NOUN
iajs-3527	72	8	,	,	PUNCT
iajs-3527	72	9	high	high	ADJ
iajs-3527	72	10	blood	blood	NOUN
iajs-3527	72	11	pressure	pressure	NOUN
iajs-3527	72	12	,	,	PUNCT
iajs-3527	72	13	and	and	CCONJ
iajs-3527	72	14	other	other	ADJ
iajs-3527	72	15	metabolic	metabolic	NOUN
iajs-3527	72	16	syndromes	syndrome	NOUN
iajs-3527	72	17	(	(	PUNCT
iajs-3527	72	18	22	22	NUM
iajs-3527	72	19	)	)	PUNCT
iajs-3527	72	20	.	.	PUNCT
iajs-3527	73	1	high	high	ADJ
iajs-3527	73	2	bmi	bmi	NOUN
iajs-3527	73	3	is	be	AUX
iajs-3527	73	4	considered	consider	VERB
iajs-3527	73	5	a	a	DET
iajs-3527	73	6	sign	sign	NOUN
iajs-3527	73	7	for	for	ADP
iajs-3527	73	8	coronary	coronary	ADJ
iajs-3527	73	9	heart	heart	NOUN
iajs-3527	73	10	disease	disease	NOUN
iajs-3527	73	11	(	(	PUNCT
iajs-3527	73	12	23	23	NUM
iajs-3527	73	13	)	)	PUNCT
iajs-3527	73	14	.	.	PUNCT
iajs-3527	74	1	also	also	ADV
iajs-3527	74	2	,	,	PUNCT
iajs-3527	74	3	inflammatory	inflammatory	ADJ
iajs-3527	74	4	parameters	parameter	NOUN
iajs-3527	74	5	can	can	AUX
iajs-3527	74	6	be	be	AUX
iajs-3527	74	7	indicators	indicator	NOUN
iajs-3527	74	8	for	for	ADP
iajs-3527	74	9	cardiovascular	cardiovascular	ADJ
iajs-3527	74	10	diseases	disease	NOUN
iajs-3527	74	11	(	(	PUNCT
iajs-3527	74	12	cvd	cvd	NOUN
iajs-3527	74	13	)	)	PUNCT
iajs-3527	74	14	in	in	ADP
iajs-3527	74	15	postmenopausal	postmenopausal	ADJ
iajs-3527	74	16	women	woman	NOUN
iajs-3527	74	17	(	(	PUNCT
iajs-3527	74	18	24	24	NUM
iajs-3527	74	19	)	)	PUNCT
iajs-3527	74	20	.	.	PUNCT
iajs-3527	75	1	c	c	X
iajs-3527	75	2	-	-	PUNCT
iajs-3527	75	3	reactive	reactive	ADJ
iajs-3527	75	4	protein	protein	NOUN
iajs-3527	75	5	crp	crp	PROPN
iajs-3527	75	6	elevated	elevate	VERB
iajs-3527	75	7	levels	level	NOUN
iajs-3527	75	8	in	in	ADP
iajs-3527	75	9	iraqi	iraqi	ADJ
iajs-3527	75	10	postmenopausal	postmenopausal	ADJ
iajs-3527	75	11	women	woman	NOUN
iajs-3527	75	12	(	(	PUNCT
iajs-3527	75	13	25	25	NUM
iajs-3527	75	14	)	)	PUNCT
iajs-3527	75	15	.	.	PUNCT
iajs-3527	76	1	the	the	DET
iajs-3527	76	2	crp	crp	PROPN
iajs-3527	76	3	with	with	ADP
iajs-3527	76	4	cvd	cvd	PROPN
iajs-3527	76	5	count	count	VERB
iajs-3527	76	6	as	as	ADP
iajs-3527	76	7	a	a	DET
iajs-3527	76	8	sign	sign	NOUN
iajs-3527	76	9	for	for	ADP
iajs-3527	76	10	postmenopausal	postmenopausal	ADJ
iajs-3527	76	11	women	woman	NOUN
iajs-3527	76	12	(	(	PUNCT
iajs-3527	76	13	26	26	NUM
iajs-3527	76	14	)	)	PUNCT
iajs-3527	76	15	.	.	PUNCT
iajs-3527	77	1	also	also	ADV
iajs-3527	77	2	,	,	PUNCT
iajs-3527	77	3	raising	raise	VERB
iajs-3527	77	4	crp	crp	NOUN
iajs-3527	77	5	in	in	ADP
iajs-3527	77	6	blood	blood	NOUN
iajs-3527	77	7	serum	serum	NOUN
iajs-3527	77	8	is	be	AUX
iajs-3527	77	9	considered	consider	VERB
iajs-3527	77	10	a	a	DET
iajs-3527	77	11	very	very	ADV
iajs-3527	77	12	significant	significant	ADJ
iajs-3527	77	13	mark	mark	NOUN
iajs-3527	77	14	for	for	ADP
iajs-3527	77	15	cardiovascular	cardiovascular	ADJ
iajs-3527	77	16	diseases	disease	NOUN
iajs-3527	77	17	(	(	PUNCT
iajs-3527	77	18	cvd	cvd	PROPN
iajs-3527	77	19	)	)	PUNCT
iajs-3527	77	20	.	.	PUNCT
iajs-3527	78	1	there	there	PRON
iajs-3527	78	2	are	be	VERB
iajs-3527	78	3	many	many	ADJ
iajs-3527	78	4	factors	factor	NOUN
iajs-3527	78	5	that	that	PRON
iajs-3527	78	6	lead	lead	VERB
iajs-3527	78	7	to	to	ADP
iajs-3527	78	8	elevated	elevated	ADJ
iajs-3527	78	9	crp	crp	NOUN
iajs-3527	78	10	levels	level	NOUN
iajs-3527	78	11	,	,	PUNCT
iajs-3527	78	12	including	include	VERB
iajs-3527	78	13	smoking	smoking	NOUN
iajs-3527	78	14	,	,	PUNCT
iajs-3527	78	15	hypertension	hypertension	NOUN
iajs-3527	78	16	,	,	PUNCT
iajs-3527	78	17	and	and	CCONJ
iajs-3527	78	18	diabetes	diabetes	NOUN
iajs-3527	78	19	(	(	PUNCT
iajs-3527	78	20	27).while	27).while	NUM
iajs-3527	78	21	,	,	PUNCT
iajs-3527	78	22	tumor	tumor	NOUN
iajs-3527	78	23	necrosis	necrosis	NOUN
iajs-3527	78	24	factor	factor	NOUN
iajs-3527	78	25	alpha	alpha	NOUN
iajs-3527	78	26	plays	play	VERB
iajs-3527	78	27	a	a	DET
iajs-3527	78	28	critical	critical	ADJ
iajs-3527	78	29	role	role	NOUN
iajs-3527	78	30	in	in	ADP
iajs-3527	78	31	regulating	regulate	VERB
iajs-3527	78	32	cytokine	cytokine	NOUN
iajs-3527	78	33	networks	network	NOUN
iajs-3527	78	34	(	(	PUNCT
iajs-3527	78	35	28	28	NUM
iajs-3527	78	36	)	)	PUNCT
iajs-3527	78	37	.	.	PUNCT
iajs-3527	79	1	lately	lately	ADV
iajs-3527	79	2	evidence	evidence	NOUN
iajs-3527	79	3	clearly	clearly	ADV
iajs-3527	79	4	suggested	suggest	VERB
iajs-3527	79	5	that	that	SCONJ
iajs-3527	79	6	tnf	tnf	PROPN
iajs-3527	79	7	-	-	PUNCT
iajs-3527	79	8	alpha	alpha	NOUN
iajs-3527	79	9	has	have	VERB
iajs-3527	79	10	a	a	DET
iajs-3527	79	11	main	main	ADJ
iajs-3527	79	12	role	role	NOUN
iajs-3527	79	13	in	in	ADP
iajs-3527	79	14	inflammatory	inflammatory	ADJ
iajs-3527	79	15	mediators	mediator	NOUN
iajs-3527	79	16	that	that	PRON
iajs-3527	79	17	may	may	AUX
iajs-3527	79	18	develop	develop	VERB
iajs-3527	79	19	health	health	NOUN
iajs-3527	79	20	problems	problem	NOUN
iajs-3527	79	21	,	,	PUNCT
iajs-3527	79	22	including	include	VERB
iajs-3527	79	23	cvd	cvd	NOUN
iajs-3527	79	24	and	and	CCONJ
iajs-3527	79	25	insulin	insulin	NOUN
iajs-3527	79	26	resistance	resistance	NOUN
iajs-3527	79	27	(	(	PUNCT
iajs-3527	79	28	29	29	NUM
iajs-3527	79	29	)	)	PUNCT
iajs-3527	79	30	.	.	PUNCT
iajs-3527	80	1	additionally	additionally	ADV
iajs-3527	80	2	,	,	PUNCT
iajs-3527	80	3	the	the	DET
iajs-3527	80	4	erythrocyte	erythrocyte	PROPN
iajs-3527	80	5	sedimentation	sedimentation	NOUN
iajs-3527	80	6	rate	rate	NOUN
iajs-3527	80	7	(	(	PUNCT
iajs-3527	80	8	esr	esr	NOUN
iajs-3527	80	9	)	)	PUNCT
iajs-3527	80	10	ratio	ratio	NOUN
iajs-3527	80	11	shows	show	VERB
iajs-3527	80	12	elevation	elevation	NOUN
iajs-3527	80	13	in	in	ADP
iajs-3527	80	14	postmenopausal	postmenopausal	ADJ
iajs-3527	80	15	women	woman	NOUN
iajs-3527	80	16	that	that	PRON
iajs-3527	80	17	can	can	AUX
iajs-3527	80	18	change	change	VERB
iajs-3527	80	19	due	due	ADP
iajs-3527	80	20	to	to	ADP
iajs-3527	80	21	the	the	DET
iajs-3527	80	22	physiology	physiology	NOUN
iajs-3527	80	23	of	of	ADP
iajs-3527	80	24	the	the	DET
iajs-3527	80	25	body	body	NOUN
iajs-3527	80	26	and	and	CCONJ
iajs-3527	80	27	aging	aging	NOUN
iajs-3527	80	28	(	(	PUNCT
iajs-3527	80	29	30	30	NUM
iajs-3527	80	30	)	)	PUNCT
iajs-3527	80	31	.	.	PUNCT
iajs-3527	81	1	5	5	X
iajs-3527	81	2	.	.	X
iajs-3527	81	3	conclusion	conclusion	NOUN
iajs-3527	81	4	tumor	tumor	NOUN
iajs-3527	81	5	necrosis	necrosis	NOUN
iajs-3527	81	6	factor	factor	NOUN
iajs-3527	81	7	-	-	PUNCT
iajs-3527	81	8	alpha	alpha	NOUN
iajs-3527	81	9	changes	change	NOUN
iajs-3527	81	10	in	in	ADP
iajs-3527	81	11	postmenopausal	postmenopausal	ADJ
iajs-3527	81	12	women	woman	NOUN
iajs-3527	81	13	,	,	PUNCT
iajs-3527	81	14	with	with	ADP
iajs-3527	81	15	levels	level	NOUN
iajs-3527	81	16	of	of	ADP
iajs-3527	81	17	patient	patient	ADJ
iajs-3527	81	18	women	woman	NOUN
iajs-3527	81	19	raising	raise	VERB
iajs-3527	81	20	,	,	PUNCT
iajs-3527	81	21	while	while	SCONJ
iajs-3527	81	22	there	there	PRON
iajs-3527	81	23	were	be	VERB
iajs-3527	81	24	reduced	reduce	VERB
iajs-3527	81	25	levels	level	NOUN
iajs-3527	81	26	in	in	ADP
iajs-3527	81	27	the	the	DET
iajs-3527	81	28	control	control	NOUN
iajs-3527	81	29	group	group	NOUN
iajs-3527	81	30	.	.	PUNCT
iajs-3527	82	1	inflammatory	inflammatory	ADJ
iajs-3527	82	2	parameters	parameter	NOUN
iajs-3527	82	3	(	(	PUNCT
iajs-3527	82	4	esr	esr	PROPN
iajs-3527	82	5	,	,	PUNCT
iajs-3527	82	6	crp	crp	PROPN
iajs-3527	82	7	)	)	PUNCT
iajs-3527	82	8	both	both	PRON
iajs-3527	82	9	of	of	ADP
iajs-3527	82	10	them	they	PRON
iajs-3527	82	11	increasing	increase	VERB
iajs-3527	82	12	levels	level	NOUN
iajs-3527	82	13	in	in	ADP
iajs-3527	82	14	postmenopausal	postmenopausal	ADJ
iajs-3527	82	15	women	woman	NOUN
iajs-3527	82	16	with	with	ADP
iajs-3527	82	17	hypertension	hypertension	NOUN
iajs-3527	82	18	,	,	PUNCT
iajs-3527	82	19	and	and	CCONJ
iajs-3527	82	20	healthy	healthy	ADJ
iajs-3527	82	21	groups	group	NOUN
iajs-3527	82	22	have	have	AUX
iajs-3527	82	23	decreased	decrease	VERB
iajs-3527	82	24	levels	level	NOUN
iajs-3527	82	25	.	.	PUNCT
iajs-3527	83	1	acknowledgment	acknowledgment	NOUN
iajs-3527	83	2	sending	send	VERB
iajs-3527	83	3	all	all	DET
iajs-3527	83	4	the	the	DET
iajs-3527	83	5	respect	respect	NOUN
iajs-3527	83	6	and	and	CCONJ
iajs-3527	83	7	appreciation	appreciation	NOUN
iajs-3527	83	8	to	to	ADP
iajs-3527	83	9	baghdad	baghdad	PROPN
iajs-3527	83	10	teaching	teach	VERB
iajs-3527	83	11	hospital	hospital	NOUN
iajs-3527	83	12	and	and	CCONJ
iajs-3527	83	13	laboratory	laboratory	NOUN
iajs-3527	83	14	staff	staff	NOUN
iajs-3527	83	15	for	for	ADP
iajs-3527	83	16	supporting	support	VERB
iajs-3527	83	17	and	and	CCONJ
iajs-3527	83	18	helping	help	VERB
iajs-3527	83	19	to	to	PART
iajs-3527	83	20	complete	complete	VERB
iajs-3527	83	21	this	this	DET
iajs-3527	83	22	work	work	NOUN
iajs-3527	83	23	successfully	successfully	ADV
iajs-3527	83	24	.	.	PUNCT
iajs-3527	84	1	conflict	conflict	NOUN
iajs-3527	84	2	of	of	ADP
iajs-3527	84	3	interest	interest	NOUN
iajs-3527	84	4	the	the	DET
iajs-3527	84	5	authors	author	NOUN
iajs-3527	84	6	declare	declare	VERB
iajs-3527	84	7	that	that	SCONJ
iajs-3527	84	8	there	there	PRON
iajs-3527	84	9	are	be	VERB
iajs-3527	84	10	no	no	DET
iajs-3527	84	11	conflicts	conflict	NOUN
iajs-3527	84	12	of	of	ADP
iajs-3527	84	13	interest	interest	NOUN
iajs-3527	84	14	regarding	regard	VERB
iajs-3527	84	15	the	the	DET
iajs-3527	84	16	publication	publication	NOUN
iajs-3527	84	17	of	of	ADP
iajs-3527	84	18	this	this	DET
iajs-3527	84	19	paper	paper	NOUN
iajs-3527	84	20	.	.	PUNCT
iajs-3527	85	1	funding	fund	VERB
iajs-3527	85	2	the	the	DET
iajs-3527	85	3	authors	author	NOUN
iajs-3527	85	4	received	receive	VERB
iajs-3527	85	5	no	no	DET
iajs-3527	85	6	financial	financial	ADJ
iajs-3527	85	7	support	support	NOUN
iajs-3527	85	8	for	for	ADP
iajs-3527	85	9	the	the	DET
iajs-3527	85	10	research	research	NOUN
iajs-3527	85	11	,	,	PUNCT
iajs-3527	85	12	authorship	authorship	NOUN
iajs-3527	85	13	,	,	PUNCT
iajs-3527	85	14	or	or	CCONJ
iajs-3527	85	15	publication	publication	NOUN
iajs-3527	85	16	of	of	ADP
iajs-3527	85	17	this	this	DET
iajs-3527	85	18	article	article	NOUN
iajs-3527	85	19	.	.	PUNCT
iajs-3527	86	1	ethical	ethical	ADJ
iajs-3527	86	2	clearance	clearance	NOUN
iajs-3527	86	3	the	the	DET
iajs-3527	86	4	study	study	NOUN
iajs-3527	86	5	approved	approve	VERB
iajs-3527	86	6	by	by	ADP
iajs-3527	86	7	ethics	ethic	NOUN
iajs-3527	86	8	committees	committee	NOUN
iajs-3527	86	9	that	that	PRON
iajs-3527	86	10	referenced	reference	VERB
iajs-3527	86	11	by	by	ADP
iajs-3527	86	12	the	the	DET
iajs-3527	86	13	number	number	NOUN
iajs-3527	86	14	csec/0922/0106	csec/0922/0106	NOUN
iajs-3527	86	15	in	in	ADP
iajs-3527	86	16	28	28	NUM
iajs-3527	86	17	/9/	/9/	SYM
iajs-3527	86	18	2022	2022	NUM
iajs-3527	86	19	department	department	NOUN
iajs-3527	86	20	of	of	ADP
iajs-3527	86	21	biology	biology	NOUN
iajs-3527	86	22	/college	/college	PROPN
iajs-3527	86	23	of	of	ADP
iajs-3527	86	24	science/	science/	NUM
iajs-3527	86	25	university	university	NOUN
iajs-3527	86	26	of	of	ADP
iajs-3527	86	27	baghdad	baghdad	PROPN
iajs-3527	86	28	.	.	PUNCT
iajs-3527	87	1	ihjpas	ihjpas	PROPN
iajs-3527	87	2	.	.	PUNCT
iajs-3527	88	1	2025	2025	NUM
iajs-3527	88	2	,	,	PUNCT
iajs-3527	88	3	38(3	38(3	NUM
iajs-3527	88	4	)	)	PUNCT
iajs-3527	88	5	00	00	NUM
iajs-3527	88	6	references	reference	NOUN
iajs-3527	88	7	1	1	NUM
iajs-3527	88	8	.	.	PUNCT
iajs-3527	89	1	umemura	umemura	PROPN
iajs-3527	89	2	s	s	PROPN
iajs-3527	89	3	,	,	PUNCT
iajs-3527	89	4	arima	arima	PROPN
iajs-3527	89	5	h	h	PROPN
iajs-3527	89	6	,	,	PUNCT
iajs-3527	89	7	arima	arima	PROPN
iajs-3527	89	8	s	s	PROPN
iajs-3527	89	9	,	,	PUNCT
iajs-3527	89	10	asayama	asayama	PROPN
iajs-3527	89	11	k	k	NOUN
iajs-3527	89	12	,	,	PUNCT
iajs-3527	89	13	dohi	dohi	PROPN
iajs-3527	89	14	y	y	PROPN
iajs-3527	89	15	,	,	PUNCT
iajs-3527	89	16	hirooka	hirooka	PROPN
iajs-3527	89	17	y.	y.	PROPN
iajs-3527	90	1	the	the	DET
iajs-3527	90	2	japanese	japanese	ADJ
iajs-3527	90	3	society	society	NOUN
iajs-3527	90	4	of	of	ADP
iajs-3527	90	5	hypertension	hypertension	NOUN
iajs-3527	90	6	guidelines	guideline	NOUN
iajs-3527	90	7	for	for	ADP
iajs-3527	90	8	the	the	DET
iajs-3527	90	9	management	management	NOUN
iajs-3527	90	10	of	of	ADP
iajs-3527	90	11	hypertension	hypertension	NOUN
iajs-3527	90	12	(	(	PUNCT
iajs-3527	90	13	jsh	jsh	PROPN
iajs-3527	90	14	2019	2019	NUM
iajs-3527	90	15	)	)	PUNCT
iajs-3527	90	16	.	.	PUNCT
iajs-3527	91	1	hyperten	hyperten	PROPN
iajs-3527	91	2	res	re	NOUN
iajs-3527	91	3	.	.	PUNCT
iajs-3527	92	1	2019;42(9):1235	2019;42(9):1235	NUM
iajs-3527	92	2	-	-	SYM
iajs-3527	92	3	1248	1248	NUM
iajs-3527	92	4	.	.	PUNCT
iajs-3527	93	1	https://doi.org/10.1038/s41440-019-0284-9	https://doi.org/10.1038/s41440-019-0284-9	NUM
iajs-3527	93	2	.	.	PUNCT
iajs-3527	94	1	2	2	X
iajs-3527	94	2	.	.	X
iajs-3527	94	3	aggarwal	aggarwal	NOUN
iajs-3527	94	4	r	r	PROPN
iajs-3527	94	5	,	,	PUNCT
iajs-3527	94	6	yeh	yeh	PROPN
iajs-3527	94	7	rw	rw	PROPN
iajs-3527	94	8	,	,	PUNCT
iajs-3527	94	9	maddox	maddox	PROPN
iajs-3527	94	10	kej	kej	PROPN
iajs-3527	94	11	,	,	PUNCT
iajs-3527	94	12	wadhera	wadhera	NOUN
iajs-3527	94	13	rk	rk	NOUN
iajs-3527	94	14	.	.	PUNCT
iajs-3527	94	15	cardiovascular	cardiovascular	ADJ
iajs-3527	94	16	risk	risk	NOUN
iajs-3527	94	17	factor	factor	NOUN
iajs-3527	94	18	prevalence	prevalence	NOUN
iajs-3527	94	19	,	,	PUNCT
iajs-3527	94	20	treatment	treatment	NOUN
iajs-3527	94	21	,	,	PUNCT
iajs-3527	94	22	and	and	CCONJ
iajs-3527	94	23	control	control	NOUN
iajs-3527	94	24	in	in	ADP
iajs-3527	94	25	us	us	PROPN
iajs-3527	94	26	adults	adult	NOUN
iajs-3527	94	27	aged	aged	ADJ
iajs-3527	94	28	20	20	NUM
iajs-3527	94	29	to	to	PART
iajs-3527	94	30	44	44	NUM
iajs-3527	94	31	years	year	NOUN
iajs-3527	94	32	,	,	PUNCT
iajs-3527	94	33	2009	2009	NUM
iajs-3527	94	34	to	to	ADP
iajs-3527	94	35	march	march	PROPN
iajs-3527	94	36	2020	2020	NUM
iajs-3527	94	37	.	.	PUNCT
iajs-3527	95	1	jama	jama	NOUN
iajs-3527	95	2	.	.	PUNCT
iajs-3527	96	1	2023;329(11):899	2023;329(11):899	NUM
iajs-3527	96	2	-	-	SYM
iajs-3527	96	3	909	909	NUM
iajs-3527	96	4	.	.	PUNCT
iajs-3527	97	1	https://doi.org/10.1001/jama.2023.2307	https://doi.org/10.1001/jama.2023.2307	PROPN
iajs-3527	97	2	.	.	PUNCT
iajs-3527	98	1	3	3	NUM
iajs-3527	98	2	.	.	X
iajs-3527	98	3	suvila	suvila	PROPN
iajs-3527	99	1	k	k	PROPN
iajs-3527	99	2	,	,	PUNCT
iajs-3527	99	3	langen	langen	PROPN
iajs-3527	99	4	v	v	PROPN
iajs-3527	99	5	,	,	PUNCT
iajs-3527	99	6	cheng	cheng	PROPN
iajs-3527	99	7	s	s	PROPN
iajs-3527	99	8	,	,	PUNCT
iajs-3527	99	9	niiranen	niiranen	PROPN
iajs-3527	99	10	tj	tj	PROPN
iajs-3527	99	11	.	.	PROPN
iajs-3527	99	12	age	age	NOUN
iajs-3527	99	13	of	of	ADP
iajs-3527	99	14	hypertension	hypertension	NOUN
iajs-3527	99	15	onset	onset	NOUN
iajs-3527	99	16	:	:	PUNCT
iajs-3527	99	17	overview	overview	NOUN
iajs-3527	99	18	of	of	ADP
iajs-3527	99	19	research	research	NOUN
iajs-3527	99	20	and	and	CCONJ
iajs-3527	99	21	how	how	SCONJ
iajs-3527	99	22	to	to	PART
iajs-3527	99	23	apply	apply	VERB
iajs-3527	99	24	in	in	ADP
iajs-3527	99	25	practice	practice	NOUN
iajs-3527	99	26	.	.	PUNCT
iajs-3527	100	1	curr	curr	PROPN
iajs-3527	100	2	hyperten	hyperten	PROPN
iajs-3527	100	3	rep	rep	PROPN
iajs-3527	100	4	.	.	PROPN
iajs-3527	100	5	2020;22:1	2020;22:1	NUM
iajs-3527	100	6	-	-	PUNCT
iajs-3527	100	7	8	8	NUM
iajs-3527	100	8	.	.	PUNCT
iajs-3527	101	1	https://doi.org/10.1007/s11906-02001071-z	https://doi.org/10.1007/s11906-02001071-z	NOUN
iajs-3527	101	2	.	.	PUNCT
iajs-3527	102	1	4	4	NUM
iajs-3527	102	2	.	.	X
iajs-3527	102	3	górecka	górecka	PROPN
iajs-3527	102	4	d	d	PROPN
iajs-3527	102	5	,	,	PUNCT
iajs-3527	102	6	wawrzyniak	wawrzyniak	PROPN
iajs-3527	102	7	a	a	PRON
iajs-3527	102	8	,	,	PUNCT
iajs-3527	102	9	jędrusek	jędrusek	PROPN
iajs-3527	102	10	-	-	PUNCT
iajs-3527	102	11	golińska	golińska	PROPN
iajs-3527	102	12	a	a	PRON
iajs-3527	102	13	,	,	PUNCT
iajs-3527	102	14	dziedzic	dziedzic	PROPN
iajs-3527	102	15	k	k	NOUN
iajs-3527	102	16	,	,	PUNCT
iajs-3527	102	17	hamułka	hamułka	PROPN
iajs-3527	102	18	j	j	PROPN
iajs-3527	102	19	,	,	PUNCT
iajs-3527	102	20	kowalczewski	kowalczewski	PROPN
iajs-3527	102	21	pł	pł	PROPN
iajs-3527	102	22	.	.	PUNCT
iajs-3527	103	1	lycopene	lycopene	NOUN
iajs-3527	103	2	in	in	ADP
iajs-3527	103	3	tomatoes	tomato	NOUN
iajs-3527	103	4	and	and	CCONJ
iajs-3527	103	5	tomato	tomato	NOUN
iajs-3527	103	6	products	product	NOUN
iajs-3527	103	7	.	.	PUNCT
iajs-3527	104	1	open	open	ADJ
iajs-3527	104	2	chem	chem	NOUN
iajs-3527	104	3	.	.	PUNCT
iajs-3527	105	1	2020;18(1):752	2020;18(1):752	NUM
iajs-3527	105	2	-	-	SYM
iajs-3527	105	3	756	756	NUM
iajs-3527	105	4	.	.	PUNCT
iajs-3527	106	1	https://doi.org/10.1515/chem-2020-0050	https://doi.org/10.1515/chem-2020-0050	PROPN
iajs-3527	106	2	.	.	PUNCT
iajs-3527	107	1	5	5	X
iajs-3527	107	2	.	.	X
iajs-3527	107	3	cameron	cameron	PROPN
iajs-3527	107	4	na	na	PROPN
iajs-3527	107	5	,	,	PUNCT
iajs-3527	107	6	petito	petito	PROPN
iajs-3527	107	7	lc	lc	PROPN
iajs-3527	107	8	,	,	PUNCT
iajs-3527	107	9	mccabe	mccabe	PROPN
iajs-3527	107	10	m	m	PROPN
iajs-3527	107	11	,	,	PUNCT
iajs-3527	107	12	allen	allen	PROPN
iajs-3527	107	13	nb	nb	PROPN
iajs-3527	107	14	,	,	PUNCT
iajs-3527	107	15	o’brien	o’brien	PROPN
iajs-3527	107	16	mj	mj	PROPN
iajs-3527	107	17	,	,	PUNCT
iajs-3527	107	18	carnethon	carnethon	VERB
iajs-3527	107	19	mr	mr	PROPN
iajs-3527	107	20	.	.	PROPN
iajs-3527	107	21	quantifying	quantify	VERB
iajs-3527	107	22	the	the	DET
iajs-3527	107	23	sex	sex	NOUN
iajs-3527	107	24	-	-	PUNCT
iajs-3527	107	25	race	race	NOUN
iajs-3527	107	26	/	/	SYM
iajs-3527	107	27	ethnicity	ethnicity	NOUN
iajs-3527	107	28	-	-	PUNCT
iajs-3527	107	29	specific	specific	ADJ
iajs-3527	107	30	burden	burden	NOUN
iajs-3527	107	31	of	of	ADP
iajs-3527	107	32	obesity	obesity	NOUN
iajs-3527	107	33	on	on	ADP
iajs-3527	107	34	incident	incident	NOUN
iajs-3527	107	35	diabetes	diabetes	NOUN
iajs-3527	107	36	mellitus	mellitus	NOUN
iajs-3527	107	37	in	in	ADP
iajs-3527	107	38	the	the	DET
iajs-3527	107	39	united	united	PROPN
iajs-3527	107	40	states	states	PROPN
iajs-3527	107	41	,	,	PUNCT
iajs-3527	107	42	2001	2001	NUM
iajs-3527	107	43	to	to	ADP
iajs-3527	107	44	2016	2016	NUM
iajs-3527	107	45	:	:	PUNCT
iajs-3527	107	46	mesa	mesa	PROPN
iajs-3527	107	47	and	and	CCONJ
iajs-3527	107	48	nhanes	nhane	NOUN
iajs-3527	107	49	.	.	PUNCT
iajs-3527	108	1	j	j	PROPN
iajs-3527	108	2	am	be	AUX
iajs-3527	108	3	heart	heart	NOUN
iajs-3527	108	4	assoc	assoc	NOUN
iajs-3527	108	5	.	.	PUNCT
iajs-3527	109	1	2021;10(4):e018799	2021;10(4):e018799	X
iajs-3527	109	2	.	.	PUNCT
iajs-3527	110	1	https://doi.org/10.1161/jaha.120.018799	https://doi.org/10.1161/jaha.120.018799	NOUN
iajs-3527	110	2	.	.	PROPN
iajs-3527	111	1	6	6	NUM
iajs-3527	111	2	.	.	PUNCT
iajs-3527	111	3	jayedi	jayedi	PROPN
iajs-3527	111	4	a	a	PROPN
iajs-3527	111	5	,	,	PUNCT
iajs-3527	111	6	soltani	soltani	PROPN
iajs-3527	111	7	s	s	PROPN
iajs-3527	111	8	,	,	PUNCT
iajs-3527	111	9	motlagh	motlagh	X
iajs-3527	111	10	sz	sz	PROPN
iajs-3527	111	11	-	-	PUNCT
iajs-3527	111	12	t	t	PROPN
iajs-3527	111	13	,	,	PUNCT
iajs-3527	111	14	emadi	emadi	VERB
iajs-3527	111	15	a	a	DET
iajs-3527	111	16	,	,	PUNCT
iajs-3527	111	17	shahinfar	shahinfar	ADJ
iajs-3527	111	18	h	h	NOUN
iajs-3527	111	19	,	,	PUNCT
iajs-3527	111	20	moosavi	moosavi	ADJ
iajs-3527	111	21	h.	h.	NOUN
iajs-3527	111	22	anthropometric	anthropometric	ADJ
iajs-3527	111	23	and	and	CCONJ
iajs-3527	111	24	adiposity	adiposity	NOUN
iajs-3527	111	25	indicators	indicator	NOUN
iajs-3527	111	26	and	and	CCONJ
iajs-3527	111	27	risk	risk	NOUN
iajs-3527	111	28	of	of	ADP
iajs-3527	111	29	type	type	NOUN
iajs-3527	111	30	2	2	NUM
iajs-3527	111	31	diabetes	diabetes	NOUN
iajs-3527	111	32	:	:	PUNCT
iajs-3527	111	33	systematic	systematic	ADJ
iajs-3527	111	34	review	review	NOUN
iajs-3527	111	35	and	and	CCONJ
iajs-3527	111	36	dose	dose	NOUN
iajs-3527	111	37	-	-	PUNCT
iajs-3527	111	38	response	response	NOUN
iajs-3527	111	39	meta	meta	ADJ
iajs-3527	111	40	-	-	PUNCT
iajs-3527	111	41	analysis	analysis	NOUN
iajs-3527	111	42	of	of	ADP
iajs-3527	111	43	cohort	cohort	NOUN
iajs-3527	111	44	studies	study	NOUN
iajs-3527	111	45	.	.	PUNCT
iajs-3527	112	1	bmj	bmj	PROPN
iajs-3527	112	2	.	.	PUNCT
iajs-3527	112	3	2022;376	2022;376	NUM
iajs-3527	112	4	:	:	PUNCT
iajs-3527	113	1	e067516	e067516	PROPN
iajs-3527	113	2	.	.	PUNCT
iajs-3527	113	3	https://doi.org/10.1136/bmj-2021-067516	https://doi.org/10.1136/bmj-2021-067516	NOUN
iajs-3527	113	4	.	.	PUNCT
iajs-3527	114	1	7	7	X
iajs-3527	114	2	.	.	X
iajs-3527	114	3	comparetto	comparetto	PROPN
iajs-3527	114	4	c	c	PROPN
iajs-3527	114	5	,	,	PUNCT
iajs-3527	114	6	borruto	borruto	PROPN
iajs-3527	114	7	f.	f.	PROPN
iajs-3527	114	8	treatments	treatments	PROPN
iajs-3527	114	9	and	and	CCONJ
iajs-3527	114	10	management	management	NOUN
iajs-3527	114	11	of	of	ADP
iajs-3527	114	12	menopausal	menopausal	ADJ
iajs-3527	114	13	symptoms	symptom	NOUN
iajs-3527	114	14	:	:	PUNCT
iajs-3527	114	15	current	current	ADJ
iajs-3527	114	16	status	status	NOUN
iajs-3527	114	17	and	and	CCONJ
iajs-3527	114	18	future	future	ADJ
iajs-3527	114	19	challenges	challenge	NOUN
iajs-3527	114	20	.	.	PUNCT
iajs-3527	115	1	obm	obm	PROPN
iajs-3527	115	2	geriatr	geriatr	PROPN
iajs-3527	115	3	.	.	PUNCT
iajs-3527	116	1	2023;1	2023;1	NUM
iajs-3527	116	2	-	-	SYM
iajs-3527	116	3	47	47	NUM
iajs-3527	116	4	.	.	PUNCT
iajs-3527	117	1	http://dx.doi.org/10.21926/obm.geriatr.2303248	http://dx.doi.org/10.21926/obm.geriatr.2303248	PROPN
iajs-3527	117	2	.	.	PUNCT
iajs-3527	118	1	8	8	NUM
iajs-3527	118	2	.	.	X
iajs-3527	118	3	lopes	lopes	PROPN
iajs-3527	118	4	lc	lc	PROPN
iajs-3527	118	5	,	,	PUNCT
iajs-3527	118	6	santos	santos	PROPN
iajs-3527	118	7	a	a	PRON
iajs-3527	118	8	,	,	PUNCT
iajs-3527	118	9	bueno	bueno	PROPN
iajs-3527	118	10	pr	pr	PROPN
iajs-3527	118	11	.	.	PUNCT
iajs-3527	119	1	an	an	DET
iajs-3527	119	2	outlook	outlook	NOUN
iajs-3527	119	3	on	on	ADP
iajs-3527	119	4	electrochemical	electrochemical	ADJ
iajs-3527	119	5	approaches	approach	NOUN
iajs-3527	119	6	for	for	ADP
iajs-3527	119	7	molecular	molecular	ADJ
iajs-3527	119	8	diagnostics	diagnostic	NOUN
iajs-3527	119	9	assays	assay	NOUN
iajs-3527	119	10	and	and	CCONJ
iajs-3527	119	11	discussions	discussion	NOUN
iajs-3527	119	12	on	on	ADP
iajs-3527	119	13	the	the	DET
iajs-3527	119	14	limitations	limitation	NOUN
iajs-3527	119	15	of	of	ADP
iajs-3527	119	16	miniaturized	miniaturize	VERB
iajs-3527	119	17	technologies	technology	NOUN
iajs-3527	119	18	for	for	ADP
iajs-3527	119	19	point	point	NOUN
iajs-3527	119	20	-	-	PUNCT
iajs-3527	119	21	of	of	ADP
iajs-3527	119	22	-	-	PUNCT
iajs-3527	119	23	care	care	NOUN
iajs-3527	119	24	devices	device	NOUN
iajs-3527	119	25	.	.	PUNCT
iajs-3527	120	1	sens	sens	PROPN
iajs-3527	120	2	actuat	actuat	PROPN
iajs-3527	120	3	rep	rep	PROPN
iajs-3527	120	4	.	.	PROPN
iajs-3527	120	5	2022;4:100087	2022;4:100087	NUM
iajs-3527	120	6	.	.	PUNCT
iajs-3527	121	1	https://doi.org/10.1016/j.snr.2022.100087	https://doi.org/10.1016/j.snr.2022.100087	ADV
iajs-3527	121	2	.	.	PUNCT
iajs-3527	122	1	9	9	X
iajs-3527	122	2	.	.	X
iajs-3527	122	3	shin	shin	PROPN
iajs-3527	123	1	sh	sh	PROPN
iajs-3527	123	2	,	,	PUNCT
iajs-3527	123	3	lee	lee	PROPN
iajs-3527	123	4	yj	yj	PROPN
iajs-3527	123	5	,	,	PUNCT
iajs-3527	123	6	lee	lee	PROPN
iajs-3527	123	7	ya	ya	PROPN
iajs-3527	123	8	,	,	PUNCT
iajs-3527	123	9	kim	kim	PROPN
iajs-3527	123	10	jh	jh	PROPN
iajs-3527	123	11	,	,	PUNCT
iajs-3527	123	12	lee	lee	PROPN
iajs-3527	123	13	sy	sy	PROPN
iajs-3527	123	14	,	,	PUNCT
iajs-3527	123	15	shin	shin	PROPN
iajs-3527	123	16	ch	ch	PROPN
iajs-3527	123	17	.	.	PROPN
iajs-3527	124	1	high	high	ADJ
iajs-3527	124	2	-	-	PUNCT
iajs-3527	124	3	sensitivity	sensitivity	NOUN
iajs-3527	124	4	c	c	NOUN
iajs-3527	124	5	-	-	PUNCT
iajs-3527	124	6	reactive	reactive	ADJ
iajs-3527	124	7	protein	protein	NOUN
iajs-3527	124	8	is	be	AUX
iajs-3527	124	9	associated	associate	VERB
iajs-3527	124	10	with	with	ADP
iajs-3527	124	11	prediabetes	prediabete	NOUN
iajs-3527	124	12	and	and	CCONJ
iajs-3527	124	13	adiposity	adiposity	NOUN
iajs-3527	124	14	in	in	ADP
iajs-3527	124	15	korean	korean	ADJ
iajs-3527	124	16	youth	youth	NOUN
iajs-3527	124	17	.	.	PUNCT
iajs-3527	125	1	metab	metab	PROPN
iajs-3527	125	2	syndrome	syndrome	PROPN
iajs-3527	125	3	relat	relat	PROPN
iajs-3527	125	4	disord	disord	NOUN
iajs-3527	125	5	.	.	PUNCT
iajs-3527	126	1	2020;18(1):47	2020;18(1):47	NUM
iajs-3527	126	2	-	-	SYM
iajs-3527	126	3	55	55	NUM
iajs-3527	126	4	.	.	PUNCT
iajs-3527	127	1	https://doi.org/10.1089/met.2019.0076	https://doi.org/10.1089/met.2019.0076	ADJ
iajs-3527	127	2	.	.	PUNCT
iajs-3527	128	1	10	10	NUM
iajs-3527	128	2	.	.	PUNCT
iajs-3527	128	3	mouliou	mouliou	PROPN
iajs-3527	128	4	ds	ds	PROPN
iajs-3527	128	5	.	.	PROPN
iajs-3527	129	1	c	c	NOUN
iajs-3527	129	2	-	-	PUNCT
iajs-3527	129	3	reactive	reactive	ADJ
iajs-3527	129	4	protein	protein	NOUN
iajs-3527	129	5	:	:	PUNCT
iajs-3527	129	6	pathophysiology	pathophysiology	NOUN
iajs-3527	129	7	,	,	PUNCT
iajs-3527	129	8	diagnosis	diagnosis	NOUN
iajs-3527	129	9	,	,	PUNCT
iajs-3527	129	10	false	false	ADJ
iajs-3527	129	11	test	test	NOUN
iajs-3527	129	12	results	result	NOUN
iajs-3527	129	13	and	and	CCONJ
iajs-3527	129	14	a	a	DET
iajs-3527	129	15	novel	novel	ADJ
iajs-3527	129	16	diagnostic	diagnostic	ADJ
iajs-3527	129	17	algorithm	algorithm	NOUN
iajs-3527	129	18	for	for	ADP
iajs-3527	129	19	clinicians	clinician	NOUN
iajs-3527	129	20	.	.	PUNCT
iajs-3527	130	1	diseases	disease	NOUN
iajs-3527	130	2	.	.	PUNCT
iajs-3527	131	1	2023;11(4):132	2023;11(4):132	NUM
iajs-3527	131	2	.	.	PUNCT
iajs-3527	132	1	https://doi.org/10.3390/diseases11040132	https://doi.org/10.3390/diseases11040132	PROPN
iajs-3527	132	2	.	.	PUNCT
iajs-3527	133	1	11	11	NUM
iajs-3527	133	2	.	.	PUNCT
iajs-3527	134	1	jomova	jomova	PROPN
iajs-3527	134	2	k	k	PROPN
iajs-3527	134	3	,	,	PUNCT
iajs-3527	134	4	raptova	raptova	NOUN
iajs-3527	134	5	r	r	NOUN
iajs-3527	134	6	,	,	PUNCT
iajs-3527	134	7	alomar	alomar	PROPN
iajs-3527	134	8	sy	sy	PROPN
iajs-3527	134	9	,	,	PUNCT
iajs-3527	134	10	alwasel	alwasel	PROPN
iajs-3527	134	11	sh	sh	PROPN
iajs-3527	134	12	,	,	PUNCT
iajs-3527	134	13	nepovimova	nepovimova	X
iajs-3527	134	14	e	e	X
iajs-3527	134	15	,	,	PUNCT
iajs-3527	134	16	kuca	kuca	PROPN
iajs-3527	134	17	k.	k.	PROPN
iajs-3527	134	18	reactive	reactive	ADJ
iajs-3527	134	19	oxygen	oxygen	NOUN
iajs-3527	134	20	species	specie	NOUN
iajs-3527	134	21	,	,	PUNCT
iajs-3527	134	22	toxicity	toxicity	NOUN
iajs-3527	134	23	,	,	PUNCT
iajs-3527	134	24	oxidative	oxidative	ADJ
iajs-3527	134	25	stress	stress	NOUN
iajs-3527	134	26	,	,	PUNCT
iajs-3527	134	27	and	and	CCONJ
iajs-3527	134	28	antioxidants	antioxidant	NOUN
iajs-3527	134	29	:	:	PUNCT
iajs-3527	134	30	chronic	chronic	ADJ
iajs-3527	134	31	diseases	disease	NOUN
iajs-3527	134	32	and	and	CCONJ
iajs-3527	134	33	aging	aging	NOUN
iajs-3527	134	34	.	.	PUNCT
iajs-3527	135	1	arch	arch	ADJ
iajs-3527	135	2	toxicol	toxicol	PROPN
iajs-3527	135	3	.	.	PUNCT
iajs-3527	136	1	2023;97(10):2499	2023;97(10):2499	NUM
iajs-3527	136	2	-	-	SYM
iajs-3527	136	3	2574	2574	NUM
iajs-3527	136	4	.	.	PUNCT
iajs-3527	137	1	https://doi.org/10.1007/s00204-023-03562-9	https://doi.org/10.1007/s00204-023-03562-9	NOUN
iajs-3527	137	2	.	.	PUNCT
iajs-3527	138	1	12	12	NUM
iajs-3527	138	2	.	.	PUNCT
iajs-3527	139	1	torres	torre	VERB
iajs-3527	139	2	crigna	crigna	PROPN
iajs-3527	139	3	a	a	PRON
iajs-3527	139	4	,	,	PUNCT
iajs-3527	139	5	link	link	NOUN
iajs-3527	139	6	b	b	PROPN
iajs-3527	139	7	,	,	PUNCT
iajs-3527	139	8	samec	samec	PROPN
iajs-3527	139	9	m	m	PROPN
iajs-3527	139	10	,	,	PUNCT
iajs-3527	139	11	giordano	giordano	PROPN
iajs-3527	139	12	fa	fa	PROPN
iajs-3527	139	13	,	,	PUNCT
iajs-3527	139	14	kubatka	kubatka	PROPN
iajs-3527	139	15	p	p	PROPN
iajs-3527	139	16	,	,	PUNCT
iajs-3527	139	17	golubnitschaja	golubnitschaja	PROPN
iajs-3527	139	18	o.	o.	PROPN
iajs-3527	140	1	endothelin-1	endothelin-1	NOUN
iajs-3527	140	2	axes	axis	NOUN
iajs-3527	140	3	in	in	ADP
iajs-3527	140	4	the	the	DET
iajs-3527	140	5	framework	framework	NOUN
iajs-3527	140	6	of	of	ADP
iajs-3527	140	7	predictive	predictive	ADJ
iajs-3527	140	8	,	,	PUNCT
iajs-3527	140	9	preventive	preventive	ADJ
iajs-3527	140	10	and	and	CCONJ
iajs-3527	140	11	personalised	personalised	ADJ
iajs-3527	140	12	(	(	PUNCT
iajs-3527	140	13	3p	3p	NUM
iajs-3527	140	14	)	)	PUNCT
iajs-3527	140	15	medicine	medicine	NOUN
iajs-3527	140	16	.	.	PUNCT
iajs-3527	141	1	epma	epma	NOUN
iajs-3527	141	2	j.	j.	PROPN
iajs-3527	141	3	2021;12:265	2021;12:265	PROPN
iajs-3527	141	4	-	-	PUNCT
iajs-3527	141	5	305	305	NUM
iajs-3527	141	6	.	.	PUNCT
iajs-3527	142	1	https://doi.org/10.1007/s13167-021-00248-z	https://doi.org/10.1007/s13167-021-00248-z	NOUN
iajs-3527	142	2	.	.	PROPN
iajs-3527	142	3	13	13	NUM
iajs-3527	142	4	.	.	PUNCT
iajs-3527	143	1	li	li	PROPN
iajs-3527	143	2	s	s	PROPN
iajs-3527	143	3	,	,	PUNCT
iajs-3527	143	4	zhang	zhang	PROPN
iajs-3527	143	5	h	h	PROPN
iajs-3527	143	6	,	,	PUNCT
iajs-3527	143	7	zhu	zhu	PROPN
iajs-3527	143	8	m	m	PROPN
iajs-3527	143	9	,	,	PUNCT
iajs-3527	143	10	kuang	kuang	PROPN
iajs-3527	143	11	z	z	PROPN
iajs-3527	143	12	,	,	PUNCT
iajs-3527	143	13	li	li	PROPN
iajs-3527	143	14	x	x	PROPN
iajs-3527	143	15	,	,	PUNCT
iajs-3527	143	16	xu	xu	PROPN
iajs-3527	143	17	f.	f.	PROPN
iajs-3527	143	18	electrochemical	electrochemical	ADJ
iajs-3527	143	19	biosensors	biosensor	NOUN
iajs-3527	143	20	for	for	ADP
iajs-3527	143	21	whole	whole	ADJ
iajs-3527	143	22	blood	blood	NOUN
iajs-3527	143	23	analysis	analysis	NOUN
iajs-3527	143	24	:	:	PUNCT
iajs-3527	143	25	recent	recent	ADJ
iajs-3527	143	26	progress	progress	NOUN
iajs-3527	143	27	,	,	PUNCT
iajs-3527	143	28	challenges	challenge	NOUN
iajs-3527	143	29	,	,	PUNCT
iajs-3527	143	30	and	and	CCONJ
iajs-3527	143	31	future	future	ADJ
iajs-3527	143	32	perspectives	perspective	NOUN
iajs-3527	143	33	.	.	PUNCT
iajs-3527	144	1	chem	chem	PROPN
iajs-3527	144	2	rev	rev	VERB
iajs-3527	144	3	.	.	PUNCT
iajs-3527	145	1	2023;123(12):7953	2023;123(12):7953	NUM
iajs-3527	145	2	-	-	PUNCT
iajs-3527	145	3	8039	8039	NUM
iajs-3527	145	4	.	.	PUNCT
iajs-3527	146	1	https://doi.org/10.1021/acs.chemrev.1c00759	https://doi.org/10.1021/acs.chemrev.1c00759	ADV
iajs-3527	146	2	.	.	PUNCT
iajs-3527	147	1	14	14	NUM
iajs-3527	147	2	.	.	PUNCT
iajs-3527	148	1	caillon	caillon	PROPN
iajs-3527	148	2	a	a	PROPN
iajs-3527	148	3	,	,	PUNCT
iajs-3527	148	4	paradis	paradis	PROPN
iajs-3527	148	5	p	p	X
iajs-3527	148	6	,	,	PUNCT
iajs-3527	148	7	schiffrin	schiffrin	PROPN
iajs-3527	148	8	el	el	PROPN
iajs-3527	149	1	.	.	PROPN
iajs-3527	149	2	role	role	NOUN
iajs-3527	149	3	of	of	ADP
iajs-3527	149	4	immune	immune	ADJ
iajs-3527	149	5	cells	cell	NOUN
iajs-3527	149	6	in	in	ADP
iajs-3527	149	7	hypertension	hypertension	NOUN
iajs-3527	149	8	.	.	PUNCT
iajs-3527	150	1	br	br	PROPN
iajs-3527	150	2	j	j	PROPN
iajs-3527	150	3	pharmacol	pharmacol	PROPN
iajs-3527	150	4	.	.	PUNCT
iajs-3527	151	1	2019;176(12):1818	2019;176(12):1818	NUM
iajs-3527	151	2	-	-	SYM
iajs-3527	151	3	1828	1828	NUM
iajs-3527	151	4	.	.	PUNCT
iajs-3527	152	1	https://doi.org/10.1111/bph.14427	https://doi.org/10.1111/bph.14427	VERB
iajs-3527	152	2	.	.	PROPN
iajs-3527	152	3	15	15	NUM
iajs-3527	152	4	.	.	PUNCT
iajs-3527	153	1	santosa	santosa	PROPN
iajs-3527	153	2	a	a	PROPN
iajs-3527	153	3	,	,	PUNCT
iajs-3527	153	4	zhang	zhang	PROPN
iajs-3527	153	5	y	y	PROPN
iajs-3527	153	6	,	,	PUNCT
iajs-3527	153	7	weinehall	weinehall	PROPN
iajs-3527	153	8	l	l	NOUN
iajs-3527	153	9	,	,	PUNCT
iajs-3527	153	10	zhao	zhao	PROPN
iajs-3527	153	11	g	g	PROPN
iajs-3527	153	12	,	,	PUNCT
iajs-3527	153	13	wang	wang	PROPN
iajs-3527	153	14	n	n	CCONJ
iajs-3527	153	15	,	,	PUNCT
iajs-3527	153	16	zhao	zhao	PROPN
iajs-3527	153	17	q.	q.	PROPN
iajs-3527	153	18	gender	gender	NOUN
iajs-3527	153	19	differences	difference	NOUN
iajs-3527	153	20	and	and	CCONJ
iajs-3527	153	21	determinants	determinant	NOUN
iajs-3527	153	22	of	of	ADP
iajs-3527	153	23	prevalence	prevalence	NOUN
iajs-3527	153	24	,	,	PUNCT
iajs-3527	153	25	awareness	awareness	NOUN
iajs-3527	153	26	,	,	PUNCT
iajs-3527	153	27	treatment	treatment	NOUN
iajs-3527	153	28	and	and	CCONJ
iajs-3527	153	29	control	control	NOUN
iajs-3527	153	30	of	of	ADP
iajs-3527	153	31	hypertension	hypertension	NOUN
iajs-3527	153	32	among	among	ADP
iajs-3527	153	33	adults	adult	NOUN
iajs-3527	153	34	in	in	ADP
iajs-3527	153	35	china	china	PROPN
iajs-3527	153	36	and	and	CCONJ
iajs-3527	153	37	sweden	sweden	PROPN
iajs-3527	153	38	.	.	PUNCT
iajs-3527	154	1	bmc	bmc	ADJ
iajs-3527	154	2	public	public	ADJ
iajs-3527	154	3	health	health	NOUN
iajs-3527	154	4	.	.	PUNCT
iajs-3527	155	1	2020;20:1	2020;20:1	X
iajs-3527	155	2	-	-	SYM
iajs-3527	155	3	13	13	NUM
iajs-3527	155	4	.	.	PUNCT
iajs-3527	156	1	https://doi.org/10.1186/s12889-020-09862-4	https://doi.org/10.1186/s12889-020-09862-4	NUM
iajs-3527	156	2	.	.	PUNCT
iajs-3527	157	1	16	16	NUM
iajs-3527	157	2	.	.	PUNCT
iajs-3527	158	1	dorgbetor	dorgbetor	PROPN
iajs-3527	158	2	ci	ci	PROPN
iajs-3527	158	3	,	,	PUNCT
iajs-3527	158	4	dickson	dickson	PROPN
iajs-3527	158	5	ks	ks	PROPN
iajs-3527	158	6	,	,	PUNCT
iajs-3527	158	7	kwabena	kwabena	ADJ
iajs-3527	158	8	ameyaw	ameyaw	NOUN
iajs-3527	158	9	e	e	NOUN
iajs-3527	158	10	,	,	PUNCT
iajs-3527	158	11	setorwu	setorwu	PROPN
iajs-3527	158	12	adde	adde	PROPN
iajs-3527	158	13	k.	k.	PROPN
iajs-3527	158	14	prevalence	prevalence	PROPN
iajs-3527	158	15	and	and	CCONJ
iajs-3527	158	16	associated	associated	ADJ
iajs-3527	158	17	factors	factor	NOUN
iajs-3527	158	18	of	of	ADP
iajs-3527	158	19	hypertension	hypertension	NOUN
iajs-3527	158	20	among	among	ADP
iajs-3527	158	21	women	woman	NOUN
iajs-3527	158	22	in	in	ADP
iajs-3527	158	23	southern	southern	ADJ
iajs-3527	158	24	ghana	ghana	PROPN
iajs-3527	158	25	:	:	PUNCT
iajs-3527	158	26	evidence	evidence	NOUN
iajs-3527	158	27	from	from	ADP
iajs-3527	158	28	2014	2014	NUM
iajs-3527	158	29	gdhs	gdhs	NOUN
iajs-3527	158	30	.	.	PUNCT
iajs-3527	159	1	int	int	PROPN
iajs-3527	160	1	j	j	PROPN
iajs-3527	160	2	hyperten	hyperten	X
iajs-3527	160	3	.	.	PUNCT
iajs-3527	161	1	2022;2022:9700160	2022;2022:9700160	NUM
iajs-3527	161	2	.	.	PUNCT
iajs-3527	161	3	https://doi.org/10.1155/2022/9700160	https://doi.org/10.1155/2022/9700160	NOUN
iajs-3527	161	4	.	.	PUNCT
iajs-3527	162	1	17	17	NUM
iajs-3527	162	2	.	.	PUNCT
iajs-3527	163	1	tiruneh	tiruneh	PROPN
iajs-3527	163	2	sa	sa	PROPN
iajs-3527	163	3	,	,	PUNCT
iajs-3527	163	4	bukayaw	bukayaw	PROPN
iajs-3527	163	5	ya	ya	PROPN
iajs-3527	163	6	,	,	PUNCT
iajs-3527	163	7	yigizaw	yigizaw	PROPN
iajs-3527	163	8	st	st	PROPN
iajs-3527	163	9	,	,	PUNCT
iajs-3527	163	10	angaw	angaw	X
iajs-3527	163	11	da	da	NOUN
iajs-3527	163	12	.	.	PUNCT
iajs-3527	164	1	prevalence	prevalence	NOUN
iajs-3527	164	2	of	of	ADP
iajs-3527	164	3	hypertension	hypertension	NOUN
iajs-3527	164	4	and	and	CCONJ
iajs-3527	164	5	its	its	PRON
iajs-3527	164	6	determinants	determinant	NOUN
iajs-3527	164	7	in	in	ADP
iajs-3527	164	8	ethiopia	ethiopia	PROPN
iajs-3527	164	9	:	:	PUNCT
iajs-3527	164	10	a	a	DET
iajs-3527	164	11	systematic	systematic	ADJ
iajs-3527	164	12	review	review	NOUN
iajs-3527	164	13	and	and	CCONJ
iajs-3527	164	14	meta	meta	ADJ
iajs-3527	164	15	-	-	PUNCT
iajs-3527	164	16	analysis	analysis	NOUN
iajs-3527	164	17	.	.	PUNCT
iajs-3527	165	1	plos	plos	PROPN
iajs-3527	165	2	one	one	NUM
iajs-3527	165	3	.	.	PUNCT
iajs-3527	166	1	2020;15(12):e0244642	2020;15(12):e0244642	PROPN
iajs-3527	166	2	.	.	PUNCT
iajs-3527	167	1	https://doi.org/10.1371/journal.pone.0244642	https://doi.org/10.1371/journal.pone.0244642	PROPN
iajs-3527	167	2	.	.	PUNCT
iajs-3527	168	1	https://doi.org/10.1038/s41440-019-0284-9	https://doi.org/10.1038/s41440-019-0284-9	NUM
iajs-3527	169	1	https://doi.org/10.1001/jama.2023.2307	https://doi.org/10.1001/jama.2023.2307	PROPN
iajs-3527	169	2	https://doi.org/10.1007/s11906-020-01071-z	https://doi.org/10.1007/s11906-020-01071-z	PROPN
iajs-3527	169	3	https://doi.org/10.1007/s11906-020-01071-z	https://doi.org/10.1007/s11906-020-01071-z	PROPN
iajs-3527	169	4	https://doi.org/10.1515/chem-2020-0050	https://doi.org/10.1515/chem-2020-0050	PROPN
iajs-3527	170	1	https://doi.org/10.1161/jaha.120.018799	https://doi.org/10.1161/jaha.120.018799	PROPN
iajs-3527	170	2	https://doi.org/10.1136/bmj-2021-067516	https://doi.org/10.1136/bmj-2021-067516	VERB
iajs-3527	170	3	http://dx.doi.org/10.21926/obm.geriatr.2303248	http://dx.doi.org/10.21926/obm.geriatr.2303248	NOUN
iajs-3527	170	4	https://doi.org/10.1016/j.snr.2022.100087	https://doi.org/10.1016/j.snr.2022.100087	PUNCT
iajs-3527	170	5	https://doi.org/10.1089/met.2019.0076	https://doi.org/10.1089/met.2019.0076	PRON
iajs-3527	170	6	https://doi.org/10.3390/diseases11040132	https://doi.org/10.3390/diseases11040132	NOUN
iajs-3527	170	7	https://doi.org/10.1007/s00204-023-03562-9	https://doi.org/10.1007/s00204-023-03562-9	NUM
iajs-3527	170	8	https://doi.org/10.1007/s13167-021-00248-z	https://doi.org/10.1007/s13167-021-00248-z	PROPN
iajs-3527	170	9	https://doi.org/10.1021/acs.chemrev.1c00759	https://doi.org/10.1021/acs.chemrev.1c00759	PROPN
iajs-3527	170	10	https://doi.org/10.1111/bph.14427	https://doi.org/10.1111/bph.14427	VERB
iajs-3527	170	11	https://doi.org/10.1186/s12889-020-09862-4	https://doi.org/10.1186/s12889-020-09862-4	NUM
iajs-3527	170	12	https://doi.org/10.1155/2022/9700160	https://doi.org/10.1155/2022/9700160	NOUN
iajs-3527	170	13	https://doi.org/10.1371/journal.pone.0244642	https://doi.org/10.1371/journal.pone.0244642	PROPN
iajs-3527	170	14	ihjpas	ihjpa	NOUN
iajs-3527	170	15	.	.	PUNCT
iajs-3527	171	1	2025	2025	NUM
iajs-3527	171	2	,	,	PUNCT
iajs-3527	171	3	38(3	38(3	NUM
iajs-3527	171	4	)	)	PUNCT
iajs-3527	171	5	01	01	NUM
iajs-3527	171	6	18	18	NUM
iajs-3527	171	7	.	.	PUNCT
iajs-3527	172	1	sanuade	sanuade	PROPN
iajs-3527	172	2	oa	oa	PROPN
iajs-3527	172	3	,	,	PUNCT
iajs-3527	172	4	boatemaa	boatemaa	NOUN
iajs-3527	172	5	s	s	PART
iajs-3527	172	6	,	,	PUNCT
iajs-3527	172	7	kushitor	kushitor	PROPN
iajs-3527	172	8	mk	mk	PROPN
iajs-3527	172	9	.	.	PUNCT
iajs-3527	173	1	hypertension	hypertension	NOUN
iajs-3527	173	2	prevalence	prevalence	PROPN
iajs-3527	173	3	,	,	PUNCT
iajs-3527	173	4	awareness	awareness	NOUN
iajs-3527	173	5	,	,	PUNCT
iajs-3527	173	6	treatment	treatment	NOUN
iajs-3527	173	7	and	and	CCONJ
iajs-3527	173	8	control	control	NOUN
iajs-3527	173	9	in	in	ADP
iajs-3527	173	10	ghanaian	ghanaian	ADJ
iajs-3527	173	11	population	population	NOUN
iajs-3527	173	12	:	:	PUNCT
iajs-3527	173	13	evidence	evidence	NOUN
iajs-3527	173	14	from	from	ADP
iajs-3527	173	15	the	the	DET
iajs-3527	173	16	ghana	ghana	PROPN
iajs-3527	173	17	demographic	demographic	ADJ
iajs-3527	173	18	and	and	CCONJ
iajs-3527	173	19	health	health	NOUN
iajs-3527	173	20	survey	survey	NOUN
iajs-3527	173	21	.	.	PUNCT
iajs-3527	174	1	plos	plos	PROPN
iajs-3527	174	2	one	one	NUM
iajs-3527	174	3	.	.	PUNCT
iajs-3527	175	1	2018;13(11):e0205985	2018;13(11):e0205985	NUM
iajs-3527	175	2	.	.	PUNCT
iajs-3527	176	1	https://doi.org/10.1371/journal.pone.0205985	https://doi.org/10.1371/journal.pone.0205985	PROPN
iajs-3527	176	2	.	.	PROPN
iajs-3527	176	3	19	19	NUM
iajs-3527	176	4	.	.	PUNCT
iajs-3527	177	1	zhou	zhou	PROPN
iajs-3527	177	2	b	b	PROPN
iajs-3527	177	3	,	,	PUNCT
iajs-3527	177	4	perel	perel	NOUN
iajs-3527	177	5	p	p	NOUN
iajs-3527	177	6	,	,	PUNCT
iajs-3527	177	7	mensah	mensah	PROPN
iajs-3527	177	8	ga	ga	PROPN
iajs-3527	177	9	,	,	PUNCT
iajs-3527	177	10	ezzati	ezzati	PROPN
iajs-3527	177	11	m.	m.	PROPN
iajs-3527	177	12	global	global	ADJ
iajs-3527	177	13	epidemiology	epidemiology	NOUN
iajs-3527	177	14	,	,	PUNCT
iajs-3527	177	15	health	health	NOUN
iajs-3527	177	16	burden	burden	NOUN
iajs-3527	177	17	and	and	CCONJ
iajs-3527	177	18	effective	effective	ADJ
iajs-3527	177	19	interventions	intervention	NOUN
iajs-3527	177	20	for	for	ADP
iajs-3527	177	21	elevated	elevated	ADJ
iajs-3527	177	22	blood	blood	NOUN
iajs-3527	177	23	pressure	pressure	NOUN
iajs-3527	177	24	and	and	CCONJ
iajs-3527	177	25	hypertension	hypertension	NOUN
iajs-3527	177	26	.	.	PUNCT
iajs-3527	178	1	nat	nat	PROPN
iajs-3527	178	2	rev	rev	PROPN
iajs-3527	178	3	cardiol	cardiol	NOUN
iajs-3527	178	4	.	.	PUNCT
iajs-3527	179	1	2021;18(11):785	2021;18(11):785	NUM
iajs-3527	179	2	-	-	PUNCT
iajs-3527	179	3	802	802	NUM
iajs-3527	179	4	.	.	PUNCT
iajs-3527	180	1	https://doi.org/10.1038/s41569-021-00559-8	https://doi.org/10.1038/s41569-021-00559-8	NUM
iajs-3527	180	2	.	.	PUNCT
iajs-3527	181	1	20	20	NUM
iajs-3527	181	2	.	.	X
iajs-3527	181	3	azeez	azeez	PROPN
iajs-3527	181	4	ia	ia	PROPN
iajs-3527	181	5	,	,	PUNCT
iajs-3527	181	6	dairo	dairo	PROPN
iajs-3527	181	7	md	md	PROPN
iajs-3527	181	8	,	,	PUNCT
iajs-3527	181	9	akinyemi	akinyemi	PROPN
iajs-3527	181	10	jo	jo	PROPN
iajs-3527	181	11	,	,	PUNCT
iajs-3527	181	12	idowu	idowu	NOUN
iajs-3527	181	13	op	op	NOUN
iajs-3527	181	14	.	.	PUNCT
iajs-3527	182	1	predictors	predictor	NOUN
iajs-3527	182	2	of	of	ADP
iajs-3527	182	3	blood	blood	NOUN
iajs-3527	182	4	pressure	pressure	NOUN
iajs-3527	182	5	levels	level	NOUN
iajs-3527	182	6	,	,	PUNCT
iajs-3527	182	7	knowledge	knowledge	NOUN
iajs-3527	182	8	and	and	CCONJ
iajs-3527	182	9	practices	practice	NOUN
iajs-3527	182	10	of	of	ADP
iajs-3527	182	11	adult	adult	NOUN
iajs-3527	182	12	hypertensives	hypertensive	NOUN
iajs-3527	182	13	attending	attend	VERB
iajs-3527	182	14	a	a	DET
iajs-3527	182	15	secondary	secondary	ADJ
iajs-3527	182	16	health	health	NOUN
iajs-3527	182	17	care	care	NOUN
iajs-3527	182	18	centre	centre	NOUN
iajs-3527	182	19	in	in	ADP
iajs-3527	182	20	south	south	ADJ
iajs-3527	182	21	-	-	PUNCT
iajs-3527	182	22	western	western	ADJ
iajs-3527	182	23	nigeria	nigeria	PROPN
iajs-3527	182	24	.	.	PUNCT
iajs-3527	183	1	europ	europ	PROPN
iajs-3527	184	1	j	j	PROPN
iajs-3527	184	2	clin	clin	PROPN
iajs-3527	184	3	exper	exper	PROPN
iajs-3527	184	4	med	med	PROPN
iajs-3527	184	5	.	.	PUNCT
iajs-3527	185	1	2022;10(3):290	2022;10(3):290	NUM
iajs-3527	185	2	-	-	SYM
iajs-3527	185	3	297	297	NUM
iajs-3527	185	4	.	.	PUNCT
iajs-3527	186	1	http://dx.doi.org/10.15584/ejcem.2022.3.6	http://dx.doi.org/10.15584/ejcem.2022.3.6	PROPN
iajs-3527	186	2	.	.	PUNCT
iajs-3527	187	1	21	21	NUM
iajs-3527	187	2	.	.	PUNCT
iajs-3527	188	1	hossain	hossain	PROPN
iajs-3527	188	2	fb	fb	PROPN
iajs-3527	188	3	,	,	PUNCT
iajs-3527	188	4	adhikary	adhikary	ADJ
iajs-3527	188	5	g	g	PROPN
iajs-3527	188	6	,	,	PUNCT
iajs-3527	188	7	chowdhury	chowdhury	PROPN
iajs-3527	188	8	ab	ab	PROPN
iajs-3527	188	9	,	,	PUNCT
iajs-3527	188	10	shawon	shawon	PROPN
iajs-3527	188	11	msr	msr	PROPN
iajs-3527	188	12	.	.	PUNCT
iajs-3527	188	13	association	association	PROPN
iajs-3527	188	14	between	between	ADP
iajs-3527	188	15	body	body	NOUN
iajs-3527	188	16	mass	mass	NOUN
iajs-3527	188	17	index	index	NOUN
iajs-3527	188	18	(	(	PUNCT
iajs-3527	188	19	bmi	bmi	PROPN
iajs-3527	188	20	)	)	PUNCT
iajs-3527	188	21	and	and	CCONJ
iajs-3527	188	22	hypertension	hypertension	NOUN
iajs-3527	188	23	in	in	ADP
iajs-3527	188	24	south	south	ADJ
iajs-3527	188	25	asian	asian	ADJ
iajs-3527	188	26	population	population	NOUN
iajs-3527	188	27	:	:	PUNCT
iajs-3527	188	28	evidence	evidence	NOUN
iajs-3527	188	29	from	from	ADP
iajs-3527	188	30	nationally	nationally	ADV
iajs-3527	188	31	-	-	PUNCT
iajs-3527	188	32	representative	representative	NOUN
iajs-3527	188	33	surveys	survey	NOUN
iajs-3527	188	34	.	.	PUNCT
iajs-3527	189	1	clin	clin	PROPN
iajs-3527	189	2	hyperten	hyperten	PROPN
iajs-3527	189	3	.	.	PUNCT
iajs-3527	190	1	2019;25:1	2019;25:1	NOUN
iajs-3527	190	2	-	-	SYM
iajs-3527	190	3	9	9	NUM
iajs-3527	190	4	.	.	PUNCT
iajs-3527	191	1	https://doi.org/10.1186/s40885-019-0134-8	https://doi.org/10.1186/s40885-019-0134-8	NUM
iajs-3527	191	2	.	.	PUNCT
iajs-3527	192	1	22	22	NUM
iajs-3527	192	2	.	.	PUNCT
iajs-3527	193	1	ambikairajah	ambikairajah	PROPN
iajs-3527	193	2	a	a	PRON
iajs-3527	193	3	,	,	PUNCT
iajs-3527	193	4	walsh	walsh	PROPN
iajs-3527	193	5	e	e	PROPN
iajs-3527	193	6	,	,	PUNCT
iajs-3527	193	7	cherbuin	cherbuin	PROPN
iajs-3527	193	8	n.	n.	PROPN
iajs-3527	193	9	a	a	DET
iajs-3527	193	10	review	review	NOUN
iajs-3527	193	11	of	of	ADP
iajs-3527	193	12	menopause	menopause	NOUN
iajs-3527	193	13	nomenclature	nomenclature	NOUN
iajs-3527	193	14	.	.	PUNCT
iajs-3527	194	1	reprod	reprod	PROPN
iajs-3527	194	2	health	health	NOUN
iajs-3527	194	3	.	.	PUNCT
iajs-3527	195	1	2022;19(1):29	2022;19(1):29	X
iajs-3527	195	2	.	.	PUNCT
iajs-3527	196	1	https://doi.org/10.1186/s12978-022-01336-7	https://doi.org/10.1186/s12978-022-01336-7	PROPN
iajs-3527	196	2	.	.	PUNCT
iajs-3527	197	1	23	23	NUM
iajs-3527	197	2	.	.	PUNCT
iajs-3527	198	1	lei	lei	PROPN
iajs-3527	198	2	l	l	PROPN
iajs-3527	198	3	,	,	PUNCT
iajs-3527	198	4	hui	hui	PROPN
iajs-3527	198	5	s	s	PROPN
iajs-3527	198	6	,	,	PUNCT
iajs-3527	198	7	chen	chen	PROPN
iajs-3527	198	8	y	y	PROPN
iajs-3527	198	9	,	,	PUNCT
iajs-3527	198	10	yan	yan	PROPN
iajs-3527	198	11	h	h	PROPN
iajs-3527	198	12	,	,	PUNCT
iajs-3527	198	13	yang	yang	PROPN
iajs-3527	198	14	j	j	PROPN
iajs-3527	198	15	,	,	PUNCT
iajs-3527	198	16	tong	tong	PROPN
iajs-3527	198	17	s.	s.	PROPN
iajs-3527	198	18	effect	effect	NOUN
iajs-3527	198	19	of	of	ADP
iajs-3527	198	20	soy	soy	NOUN
iajs-3527	198	21	isoflavone	isoflavone	NOUN
iajs-3527	198	22	supplementation	supplementation	NOUN
iajs-3527	198	23	on	on	ADP
iajs-3527	198	24	blood	blood	NOUN
iajs-3527	198	25	pressure	pressure	NOUN
iajs-3527	198	26	:	:	PUNCT
iajs-3527	198	27	a	a	DET
iajs-3527	198	28	meta	meta	ADJ
iajs-3527	198	29	-	-	PUNCT
iajs-3527	198	30	analysis	analysis	NOUN
iajs-3527	198	31	of	of	ADP
iajs-3527	198	32	randomized	randomized	ADJ
iajs-3527	198	33	controlled	control	VERB
iajs-3527	198	34	trials	trial	NOUN
iajs-3527	198	35	.	.	PUNCT
iajs-3527	199	1	nut	nut	PROPN
iajs-3527	199	2	j.	j.	PROPN
iajs-3527	199	3	2024;23(1):32	2024;23(1):32	PROPN
iajs-3527	199	4	.	.	PUNCT
iajs-3527	200	1	https://doi.org/10.1186/s12937-024-00932-6	https://doi.org/10.1186/s12937-024-00932-6	PROPN
iajs-3527	200	2	.	.	PUNCT
iajs-3527	201	1	24	24	NUM
iajs-3527	201	2	.	.	PUNCT
iajs-3527	202	1	el	el	PROPN
iajs-3527	202	2	khoudary	khoudary	PROPN
iajs-3527	202	3	sr	sr	PROPN
iajs-3527	202	4	,	,	PUNCT
iajs-3527	202	5	aggarwal	aggarwal	PROPN
iajs-3527	202	6	b	b	PROPN
iajs-3527	202	7	,	,	PUNCT
iajs-3527	202	8	beckie	beckie	PROPN
iajs-3527	202	9	tm	tm	PROPN
iajs-3527	202	10	,	,	PUNCT
iajs-3527	202	11	hodis	hodis	ADJ
iajs-3527	202	12	hn	hn	PROPN
iajs-3527	202	13	,	,	PUNCT
iajs-3527	202	14	johnson	johnson	PROPN
iajs-3527	202	15	ae	ae	PROPN
iajs-3527	202	16	,	,	PUNCT
iajs-3527	202	17	langer	langer	PROPN
iajs-3527	202	18	rd	rd	PROPN
iajs-3527	202	19	.	.	PUNCT
iajs-3527	203	1	menopause	menopause	NOUN
iajs-3527	203	2	transition	transition	NOUN
iajs-3527	203	3	and	and	CCONJ
iajs-3527	203	4	cardiovascular	cardiovascular	ADJ
iajs-3527	203	5	disease	disease	NOUN
iajs-3527	203	6	risk	risk	NOUN
iajs-3527	203	7	:	:	PUNCT
iajs-3527	203	8	implications	implication	NOUN
iajs-3527	203	9	for	for	ADP
iajs-3527	203	10	timing	timing	NOUN
iajs-3527	203	11	of	of	ADP
iajs-3527	203	12	early	early	ADJ
iajs-3527	203	13	prevention	prevention	NOUN
iajs-3527	203	14	:	:	PUNCT
iajs-3527	203	15	a	a	DET
iajs-3527	203	16	scientific	scientific	ADJ
iajs-3527	203	17	statement	statement	NOUN
iajs-3527	203	18	from	from	ADP
iajs-3527	203	19	the	the	DET
iajs-3527	203	20	american	american	PROPN
iajs-3527	203	21	heart	heart	PROPN
iajs-3527	203	22	association	association	PROPN
iajs-3527	203	23	.	.	PUNCT
iajs-3527	204	1	circulation	circulation	NOUN
iajs-3527	204	2	.	.	PUNCT
iajs-3527	205	1	2020;142(25):e506	2020;142(25):e506	NUM
iajs-3527	205	2	-	-	PUNCT
iajs-3527	205	3	e532	e532	PROPN
iajs-3527	205	4	.	.	PUNCT
iajs-3527	206	1	https://doi.org/10.1161/cir.0000000000000912	https://doi.org/10.1161/cir.0000000000000912	PROPN
iajs-3527	206	2	.	.	PROPN
iajs-3527	206	3	25	25	NUM
iajs-3527	206	4	.	.	PUNCT
iajs-3527	207	1	mohammed	mohammed	PROPN
iajs-3527	207	2	f	f	PROPN
iajs-3527	207	3	,	,	PUNCT
iajs-3527	207	4	shafiq	shafiq	PROPN
iajs-3527	207	5	n	n	PART
iajs-3527	207	6	,	,	PUNCT
iajs-3527	207	7	abdulhameed	abdulhameed	PROPN
iajs-3527	207	8	e.	e.	PROPN
iajs-3527	207	9	high	high	PROPN
iajs-3527	207	10	sensitive	sensitive	ADJ
iajs-3527	207	11	c	c	NOUN
iajs-3527	207	12	-	-	ADJ
iajs-3527	207	13	reactive	reactive	ADJ
iajs-3527	207	14	protein	protein	NOUN
iajs-3527	207	15	levels	level	NOUN
iajs-3527	207	16	in	in	ADP
iajs-3527	207	17	preand	preand	NOUN
iajs-3527	207	18	post	post	ADJ
iajs-3527	207	19	-	-	ADJ
iajs-3527	207	20	menopausal	menopausal	ADJ
iajs-3527	207	21	healthy	healthy	ADJ
iajs-3527	207	22	women	woman	NOUN
iajs-3527	207	23	in	in	ADP
iajs-3527	207	24	kirkuk	kirkuk	PROPN
iajs-3527	207	25	city	city	PROPN
iajs-3527	207	26	,	,	PUNCT
iajs-3527	207	27	iraq	iraq	PROPN
iajs-3527	207	28	.	.	PUNCT
iajs-3527	208	1	int	int	PROPN
iajs-3527	208	2	j	j	PROPN
iajs-3527	208	3	vaccines	vaccine	NOUN
iajs-3527	208	4	vaccin	vaccin	NOUN
iajs-3527	208	5	.	.	PUNCT
iajs-3527	209	1	2016;2(1):21	2016;2(1):21	NUM
iajs-3527	209	2	-	-	SYM
iajs-3527	209	3	27	27	NUM
iajs-3527	209	4	.	.	PUNCT
iajs-3527	210	1	26	26	NUM
iajs-3527	210	2	.	.	PUNCT
iajs-3527	211	1	paquette	paquette	PROPN
iajs-3527	211	2	m	m	PROPN
iajs-3527	211	3	,	,	PUNCT
iajs-3527	211	4	larqué	larqué	PROPN
iajs-3527	211	5	asm	asm	NOUN
iajs-3527	211	6	,	,	PUNCT
iajs-3527	211	7	weisnagel	weisnagel	NOUN
iajs-3527	211	8	s	s	PROPN
iajs-3527	211	9	,	,	PUNCT
iajs-3527	211	10	desjardins	desjardins	PROPN
iajs-3527	211	11	y	y	PROPN
iajs-3527	211	12	,	,	PUNCT
iajs-3527	211	13	marois	marois	PROPN
iajs-3527	211	14	j	j	PROPN
iajs-3527	211	15	,	,	PUNCT
iajs-3527	211	16	pilon	pilon	PROPN
iajs-3527	211	17	g.	g.	PROPN
iajs-3527	211	18	strawberry	strawberry	PROPN
iajs-3527	211	19	and	and	CCONJ
iajs-3527	211	20	cranberry	cranberry	NOUN
iajs-3527	211	21	polyphenols	polyphenol	NOUN
iajs-3527	211	22	improve	improve	VERB
iajs-3527	211	23	insulin	insulin	NOUN
iajs-3527	211	24	sensitivity	sensitivity	NOUN
iajs-3527	211	25	in	in	ADP
iajs-3527	211	26	insulin	insulin	NOUN
iajs-3527	211	27	-	-	PUNCT
iajs-3527	211	28	resistant	resistant	ADJ
iajs-3527	211	29	,	,	PUNCT
iajs-3527	211	30	non	non	ADJ
iajs-3527	211	31	-	-	ADJ
iajs-3527	211	32	diabetic	diabetic	ADJ
iajs-3527	211	33	adults	adult	NOUN
iajs-3527	211	34	:	:	PUNCT
iajs-3527	211	35	a	a	DET
iajs-3527	211	36	parallel	parallel	ADJ
iajs-3527	211	37	,	,	PUNCT
iajs-3527	211	38	double	double	ADJ
iajs-3527	211	39	-	-	PUNCT
iajs-3527	211	40	blind	blind	ADJ
iajs-3527	211	41	,	,	PUNCT
iajs-3527	211	42	controlled	control	VERB
iajs-3527	211	43	and	and	CCONJ
iajs-3527	211	44	randomised	randomise	VERB
iajs-3527	211	45	clinical	clinical	ADJ
iajs-3527	211	46	trial	trial	NOUN
iajs-3527	211	47	.	.	PUNCT
iajs-3527	212	1	br	br	PROPN
iajs-3527	212	2	j	j	PROPN
iajs-3527	212	3	nut	nut	PROPN
iajs-3527	212	4	.	.	PUNCT
iajs-3527	213	1	2017;117(4):519	2017;117(4):519	NUM
iajs-3527	213	2	-	-	SYM
iajs-3527	213	3	531	531	NUM
iajs-3527	213	4	.	.	PUNCT
iajs-3527	214	1	https://doi.org/10.1017/s0007114517000393	https://doi.org/10.1017/s0007114517000393	NUM
iajs-3527	214	2	.	.	PUNCT
iajs-3527	215	1	27	27	NUM
iajs-3527	215	2	.	.	PUNCT
iajs-3527	216	1	mach	mach	PROPN
iajs-3527	216	2	f	f	PROPN
iajs-3527	216	3	,	,	PUNCT
iajs-3527	216	4	baigent	baigent	ADJ
iajs-3527	216	5	c	c	X
iajs-3527	216	6	,	,	PUNCT
iajs-3527	216	7	catapano	catapano	PROPN
iajs-3527	216	8	al	al	PROPN
iajs-3527	216	9	,	,	PUNCT
iajs-3527	216	10	koskinas	koskinas	PROPN
iajs-3527	216	11	kc	kc	PROPN
iajs-3527	216	12	,	,	PUNCT
iajs-3527	216	13	casula	casula	VERB
iajs-3527	216	14	m	m	PROPN
iajs-3527	216	15	,	,	PUNCT
iajs-3527	216	16	badimon	badimon	PROPN
iajs-3527	216	17	l.	l.	PROPN
iajs-3527	216	18	2019	2019	NUM
iajs-3527	216	19	esc	esc	PROPN
iajs-3527	216	20	/	/	SYM
iajs-3527	216	21	eas	eas	NOUN
iajs-3527	216	22	guidelines	guideline	NOUN
iajs-3527	216	23	for	for	ADP
iajs-3527	216	24	the	the	DET
iajs-3527	216	25	management	management	NOUN
iajs-3527	216	26	of	of	ADP
iajs-3527	216	27	dyslipidaemias	dyslipidaemia	NOUN
iajs-3527	216	28	:	:	PUNCT
iajs-3527	216	29	lipid	lipid	NOUN
iajs-3527	216	30	modification	modification	NOUN
iajs-3527	216	31	to	to	PART
iajs-3527	216	32	reduce	reduce	VERB
iajs-3527	216	33	cardiovascular	cardiovascular	ADJ
iajs-3527	216	34	risk	risk	NOUN
iajs-3527	216	35	:	:	PUNCT
iajs-3527	216	36	the	the	DET
iajs-3527	216	37	task	task	NOUN
iajs-3527	216	38	force	force	NOUN
iajs-3527	216	39	for	for	ADP
iajs-3527	216	40	the	the	DET
iajs-3527	216	41	management	management	NOUN
iajs-3527	216	42	of	of	ADP
iajs-3527	216	43	dyslipidaemias	dyslipidaemia	NOUN
iajs-3527	216	44	of	of	ADP
iajs-3527	216	45	the	the	DET
iajs-3527	216	46	european	european	ADJ
iajs-3527	216	47	society	society	NOUN
iajs-3527	216	48	of	of	ADP
iajs-3527	216	49	cardiology	cardiology	NOUN
iajs-3527	216	50	and	and	CCONJ
iajs-3527	216	51	european	european	ADJ
iajs-3527	216	52	atherosclerosis	atherosclerosis	NOUN
iajs-3527	216	53	society	society	NOUN
iajs-3527	216	54	.	.	PUNCT
iajs-3527	217	1	europ	europ	NOUN
iajs-3527	217	2	heart	heart	NOUN
iajs-3527	217	3	j.	j.	PROPN
iajs-3527	217	4	2020;41(1):111	2020;41(1):111	PROPN
iajs-3527	217	5	-	-	NUM
iajs-3527	217	6	188	188	NUM
iajs-3527	217	7	.	.	PUNCT
iajs-3527	218	1	https://doi.org/10.1093/eurheartj/ehz455	https://doi.org/10.1093/eurheartj/ehz455	INTJ
iajs-3527	218	2	.	.	PROPN
iajs-3527	218	3	28	28	NUM
iajs-3527	218	4	.	.	PUNCT
iajs-3527	219	1	thakur	thakur	PROPN
iajs-3527	219	2	s	s	PROPN
iajs-3527	219	3	,	,	PUNCT
iajs-3527	219	4	anjum	anjum	PROPN
iajs-3527	219	5	mm	mm	PROPN
iajs-3527	219	6	,	,	PUNCT
iajs-3527	219	7	jaiswal	jaiswal	PROPN
iajs-3527	219	8	s	s	PROPN
iajs-3527	219	9	,	,	PUNCT
iajs-3527	219	10	kumar	kumar	PROPN
iajs-3527	219	11	a	a	PROPN
iajs-3527	219	12	,	,	PUNCT
iajs-3527	219	13	deepak	deepak	PROPN
iajs-3527	219	14	p	p	PROPN
iajs-3527	219	15	,	,	PUNCT
iajs-3527	219	16	anand	anand	PROPN
iajs-3527	219	17	s.	s.	PROPN
iajs-3527	219	18	novel	novel	PROPN
iajs-3527	219	19	synergistic	synergistic	ADJ
iajs-3527	219	20	approach	approach	NOUN
iajs-3527	219	21	:	:	PUNCT
iajs-3527	219	22	tazarotene	tazarotene	NOUN
iajs-3527	219	23	-	-	PUNCT
iajs-3527	219	24	calcipotriol	calcipotriol	NOUN
iajs-3527	219	25	-	-	PUNCT
iajs-3527	219	26	loaded	load	VERB
iajs-3527	219	27	pva	pva	NOUN
iajs-3527	219	28	/	/	SYM
iajs-3527	219	29	pvp	pvp	NOUN
iajs-3527	219	30	nanofibers	nanofiber	NOUN
iajs-3527	219	31	incorporated	incorporate	VERB
iajs-3527	219	32	in	in	ADP
iajs-3527	219	33	hydrogel	hydrogel	NOUN
iajs-3527	219	34	film	film	NOUN
iajs-3527	219	35	for	for	ADP
iajs-3527	219	36	management	management	NOUN
iajs-3527	219	37	and	and	CCONJ
iajs-3527	219	38	treatment	treatment	NOUN
iajs-3527	219	39	of	of	ADP
iajs-3527	219	40	psoriasis	psoriasis	NOUN
iajs-3527	219	41	.	.	PUNCT
iajs-3527	220	1	mol	mol	ADP
iajs-3527	220	2	pharmac	pharmac	NOUN
iajs-3527	220	3	.	.	PUNCT
iajs-3527	221	1	2023;20(2):997	2023;20(2):997	NUM
iajs-3527	221	2	-	-	SYM
iajs-3527	221	3	1014	1014	NUM
iajs-3527	221	4	.	.	PUNCT
iajs-3527	222	1	https://doi.org/10.1021/acs.molpharmaceut.2c00713	https://doi.org/10.1021/acs.molpharmaceut.2c00713	PROPN
iajs-3527	222	2	.	.	PUNCT
iajs-3527	223	1	29	29	NUM
iajs-3527	223	2	.	.	PUNCT
iajs-3527	224	1	reina	reina	PROPN
iajs-3527	224	2	-	-	PUNCT
iajs-3527	224	3	couto	couto	PROPN
iajs-3527	224	4	m	m	PROPN
iajs-3527	224	5	,	,	PUNCT
iajs-3527	224	6	pereira	pereira	PROPN
iajs-3527	224	7	-	-	PUNCT
iajs-3527	224	8	terra	terra	NOUN
iajs-3527	224	9	p	p	X
iajs-3527	224	10	,	,	PUNCT
iajs-3527	224	11	quelhas	quelha	NOUN
iajs-3527	224	12	-	-	PUNCT
iajs-3527	224	13	santos	santos	PROPN
iajs-3527	224	14	j	j	PROPN
iajs-3527	224	15	,	,	PUNCT
iajs-3527	224	16	silva	silva	PROPN
iajs-3527	224	17	-	-	PUNCT
iajs-3527	224	18	pereira	pereira	PROPN
iajs-3527	224	19	c	c	PROPN
iajs-3527	224	20	,	,	PUNCT
iajs-3527	224	21	albino	albino	PROPN
iajs-3527	224	22	-	-	PUNCT
iajs-3527	224	23	teixeira	teixeira	PROPN
iajs-3527	224	24	a	a	PROPN
iajs-3527	224	25	,	,	PUNCT
iajs-3527	224	26	sousa	sousa	NOUN
iajs-3527	224	27	t.	t.	PROPN
iajs-3527	224	28	inflammation	inflammation	NOUN
iajs-3527	224	29	in	in	ADP
iajs-3527	224	30	human	human	ADJ
iajs-3527	224	31	heart	heart	NOUN
iajs-3527	224	32	failure	failure	NOUN
iajs-3527	224	33	:	:	PUNCT
iajs-3527	224	34	major	major	ADJ
iajs-3527	224	35	mediators	mediator	NOUN
iajs-3527	224	36	and	and	CCONJ
iajs-3527	224	37	therapeutic	therapeutic	ADJ
iajs-3527	224	38	targets	target	NOUN
iajs-3527	224	39	.	.	PUNCT
iajs-3527	225	1	front	front	ADJ
iajs-3527	225	2	physiol	physiol	PROPN
iajs-3527	225	3	.	.	PUNCT
iajs-3527	226	1	2021;12:746494	2021;12:746494	NUM
iajs-3527	226	2	.	.	PUNCT
iajs-3527	227	1	https://doi.org/10.3389/fphys.2021.746494	https://doi.org/10.3389/fphys.2021.746494	PROPN
iajs-3527	227	2	.	.	PUNCT
iajs-3527	228	1	30	30	NUM
iajs-3527	228	2	.	.	PUNCT
iajs-3527	228	3	eledo	eledo	PROPN
iajs-3527	228	4	bo	bo	PROPN
iajs-3527	228	5	,	,	PUNCT
iajs-3527	228	6	igwe	igwe	PROPN
iajs-3527	228	7	mu	mu	PROPN
iajs-3527	228	8	,	,	PUNCT
iajs-3527	228	9	izah	izah	PROPN
iajs-3527	228	10	sc	sc	PROPN
iajs-3527	228	11	.	.	PUNCT
iajs-3527	229	1	evaluation	evaluation	NOUN
iajs-3527	229	2	of	of	ADP
iajs-3527	229	3	total	total	ADJ
iajs-3527	229	4	white	white	ADJ
iajs-3527	229	5	blood	blood	NOUN
iajs-3527	229	6	cells	cell	NOUN
iajs-3527	229	7	and	and	CCONJ
iajs-3527	229	8	cluster	cluster	NOUN
iajs-3527	229	9	of	of	ADP
iajs-3527	229	10	differentiation	differentiation	NOUN
iajs-3527	229	11	4	4	NUM
iajs-3527	229	12	cells	cell	NOUN
iajs-3527	229	13	among	among	ADP
iajs-3527	229	14	post	post	ADJ
iajs-3527	229	15	-	-	ADJ
iajs-3527	229	16	menopausal	menopausal	ADJ
iajs-3527	229	17	women	woman	NOUN
iajs-3527	229	18	in	in	ADP
iajs-3527	229	19	elele	elele	PROPN
iajs-3527	229	20	,	,	PUNCT
iajs-3527	229	21	nigeria	nigeria	PROPN
iajs-3527	229	22	.	.	PUNCT
iajs-3527	230	1	modern	modern	ADJ
iajs-3527	230	2	res	re	NOUN
iajs-3527	230	3	inflamm	inflamm	NOUN
iajs-3527	230	4	.	.	PUNCT
iajs-3527	231	1	2018;7(2):21	2018;7(2):21	NUM
iajs-3527	231	2	-	-	SYM
iajs-3527	231	3	29	29	NUM
iajs-3527	231	4	.	.	PUNCT
iajs-3527	232	1	https://doi.org/10.4236/mri.2018.72003	https://doi.org/10.4236/mri.2018.72003	NOUN
iajs-3527	232	2	.	.	PUNCT
iajs-3527	233	1	https://doi.org/10.1371/journal.pone.0205985	https://doi.org/10.1371/journal.pone.0205985	NOUN
iajs-3527	233	2	https://doi.org/10.1038/s41569-021-00559-8	https://doi.org/10.1038/s41569-021-00559-8	PROPN
iajs-3527	234	1	http://dx.doi.org/10.15584/ejcem.2022.3.6	http://dx.doi.org/10.15584/ejcem.2022.3.6	PROPN
iajs-3527	234	2	https://doi.org/10.1186/s40885-019-0134-8	https://doi.org/10.1186/s40885-019-0134-8	NUM
iajs-3527	234	3	https://doi.org/10.1186/s12978-022-01336-7	https://doi.org/10.1186/s12978-022-01336-7	NUM
iajs-3527	234	4	https://doi.org/10.1186/s12937-024-00932-6	https://doi.org/10.1186/s12937-024-00932-6	NUM
iajs-3527	234	5	https://doi.org/10.1161/cir.0000000000000912	https://doi.org/10.1161/cir.0000000000000912	PROPN
iajs-3527	234	6	https://doi.org/10.1017/s0007114517000393	https://doi.org/10.1017/s0007114517000393	NUM
iajs-3527	234	7	https://doi.org/10.1093/eurheartj/ehz455	https://doi.org/10.1093/eurheartj/ehz455	NOUN
iajs-3527	234	8	https://doi.org/10.1021/acs.molpharmaceut.2c00713	https://doi.org/10.1021/acs.molpharmaceut.2c00713	PROPN
iajs-3527	234	9	https://doi.org/10.3389/fphys.2021.746494	https://doi.org/10.3389/fphys.2021.746494	PROPN
iajs-3527	234	10	https://doi.org/10.4236/mri.2018.72003	https://doi.org/10.4236/mri.2018.72003	NOUN